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I. Equilibrium Unfolding Studies of Cytochrome c
II. The Role of Helix 1 Aspartates in the Stability and Conversion of Prion Protein 
Chair: Kent Sugden, Ph.D.
ABSTRACT
In order to improve methods to study protein structure and to obtain a detailed structural 
understanding of cytochrome c equilibrium unfolding, spectra have been obtained for horse heart 
cytochrome c at equilibrium in solutions of 0 to 7 M guanidine hydrochloride (GdnHCl) using 
absorption, fluorescence, circular dichroism (CD), and attenuated total reflectance Fourier- 
transform infrared (ATR-FTIR) spectroscopies. Unfolding studies using ATR-FTIR spectroscopy 
were performed using deuterium substituted GdnHCl which enhanced the ability to measure the 
true protein IR spectrum in the amide I region where secondary structure can be deduced. Results 
of ATR-FTIR studies showed reductions in a-helix and increases in p-sheet at high denaturant 
concentrations, contrary to expectations of finding primarily random coil structure. Collectively, 
results of the various spectroscopic unfolding studies show that there are three regions of major 
conformational change. At low denaturant concentrations there is a slight decrease in the Fe- 
Met80 coordination, a loosening of a helices, and an increase in p-sheet structure. At mid-range 
GdnHCl concentrations, the changes include a significant decrease in a-helix, a complete loss of 
Fe-Met80 coordination, a dramatic increase in the Trp59-Heme distance, and increases in p-sheet, 
random structure, and turns. At high denaturant concentrations there is a slight continuation of the 
increase in the Trp59-Heme distance, a continued increase in p-sheet, and a decrease in random 
structure. These results suggest the unfolding of cytochrome c is not a two-state transition, but 
rather occurs through multiple structures with significant p-sheet structure in the denatured state.
In a separate study, the role of helix 1 aspartates in the stability and conversion of prion protein 
was investigated. Prion protein is involved in the pathogenesis of transmissible spongiform 
encephalopathy diseases, which include chronic wasting disease in deer and elk and Creutzfeldt- 
Jakob disease in humans. A key event in the pathogenesis of transmissible spongiform 
encephalopathies is the conversion of the normal a-helical prion protein, PrP-sen, to the 
abnormal, high P-sheet protease resistant form, PrP-res. It was proposed that the conversion 
mechanism involves critical interactions at helix 1 (residues 144-153) and that the helix is 
stabilized by intra-helix salt bridges between two aspartate-arginine ion pairs at positions 144 and 
148 and 147 and 151, respectively. Three mutants designed to destabilize the helix 1 salt bridges 
by replacing the aspartates with either asparagines or alanines were compared to wild type PrP 
using CD spectroscopy and cell-free conversion reactions to assess differences in secondary 
structure stability and conversion efficiency. Thermal and chemical denaturation experiments 
indicated that the overall structures of the asparagine mutants are not substantially destabilized 
but they appear to unfold differently. Cell-free conversion reactions performed using conditions 
unfavorable to salt bridge formation showed no significant differences between conversion 
efficiencies of mutant and wild type proteins. Using conditions more favorable to salt bridge 
formation, the mutant proteins converted with up to four-fold higher efficiencies than the wild 
type protein. Thus, while spectroscopic data indicate that the salt bridges do not substantially 
stabilize PrP-sen, the cell-free conversion data suggest that D144, D147 and their respective salt 
bridges stabilize the molecule against the conversion of PrP-sen to PrP-res.
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P r e f a c e
This dissertation is composed o f  two different chapters covering research 
performed in the laboratory o f  Dr. Tom Rush III at the University o f  Montana from 1998 
to 2000, and Dr. Byron Caughey at Rocky Mountain Labs from 2000 to 2003. The first 
chapter describes work performed with Dr. Rush on the equilibrium unfolding o f  
cytochrome c. The goal o f  these studies was to use spectroscopic methods to elucidate 
structural details o f  equilibrium-unfolded cytochrome c  and to investigate whether the 
protein unfolds via a two-state transition. Portions o f  the results from this chapter were 
published in the journal Biopolymers (Speare and Rush 2003). The second chapter 
describes work on the role o f  helix 1 aspartates in the stability and conversion o f  prion 
protein. These studies were started with Dr. Rush at The University o f  Montana in 2000 
and, following Dr. Rush’s departure, were completed with Dr. Caughey at Rocky 
Mountain Laboratories branch o f  the National Institutes o f  Health. The goal o f  the helix 1 
studies was to determine if  helix 1 salt bridges stabilize the structure o f  PrP-sen and play 
a role in the conversion o f  PrP-sen to the transmissible spongiform encephalopathy 
disease associated PrP-res. Portions o f  the results o f  this chapter were published in the 
Journal o f  Biological Chemistry (Speare et al. 2003). While these studies cover different 
areas o f protein chemistry, they are complementary in nature as their fundamental goals 
are to understand and determine changes in protein structure using spectroscopic 
methods.
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1. E q u i l ib r iu m  U n f o l d i n g  S t u d ie s  o f  C y t o c h r o m e  c
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A . I n t r o d u c t i o n
The determination o f  protein structure is critical for developing a detailed 
understanding o f protein function, protein misfolding related to disease, and the 
fundamental thermodynamic factors that drive protein folding (Caughey eta l. 1991b; 
Creighton 1990; Creighton et al. 1996; Dill and Shortle 1991; Dong et al. 1990; Kim and 
Baldwin 1982; Kim and Baldwin 1990; Muga e ta l. 1991a). Protein structure and folding 
have been studied since Anfmsen showed that denatured ribonuclease could be folded 
back to its native conformation in vitro (Anfinsen et al. 1961). Initially folding was 
thought to proceed by random sampling o f  all conformational possibilities to attain the 
three-dimensional structure with the lowest free energy. In 1969 however, Levinthal 
pointed out the large amount o f  time it would take to sample all o f  the possible 
conformations, even for small proteins (Levinthal 1969). This fact, combined with the 
knowledge that certain proteins refold in vitro within a few seconds, initiated efforts for 
further understanding changes in protein structure during folding (Creighton et al. 1996).
In order to be biologically active all proteins must adopt specific three- 
dimensional structures. The ability o f  proteins to fold into specific structures must be 
dictated by their primary linear amino acid sequence because genes only contain 
information that results in the creation o f  the primary linear sequence o f  amino acids that 
make up proteins and most purified proteins refold to their original native structure after 
being completely unfolded in vitro. How proteins fold into specific structures has come to 
be known as ‘the protein folding problem’. The problem can be broken down to three
2
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different but related questions (Creighton 1990): 1) by what kinetic process or pathway 
do proteins adopt their native and biologically active folded conformation? 2) What is the 
physical basis o f  the stability o f  folded conformations? 3) Why does the amino acid 
sequence determine one particular folding process and resultant three-dimensional 
structure instead o f  some other? To address the questions o f  protein folding, one must be 
able to directly determine protein structure. A  number o f  spectroscopic techniques are 
available for investigating protein structure including absorbance, fluorescence, X-ray 
diffraction, Nuclear Magnetic Resonance (NMR), circular dichroism (CD), Raman, and 
Fourier-transform infrared (FUR ) spectroscopies. O f these, X-ray diffraction and NMR  
methods provide the most highly resolved details o f  structure. However, it is not always 
feasible to use these techniques to study the more dynamic aspects o f  protein structure 
(e.g., folding/misfolding and allosteric transitions), and their complexes with large 
biological molecules or structures (e.g., protein aggregates and membranes). Protein 
structure is influenced by solvent composition (i.e., the dielectric constant), temperature, 
and pH. Thus, spectroscopic methods that are sensitive to protein structure combined 
with chemical denaturants or temperature can be used to denature proteins and investigate 
changes that occur during folding and unfolding (Arrondo et al. 1999; Elove et al. 1992; 
Filosa et al. 1999; Hamada et al. 1996; Johnson 1990; Johnson 1999; Sreenthan and 
Taylor 1971; Tsong 1973; Tsong 1974; Tsong 1975; Tsong 1976).
In the case o f  chemical denaturation, absorbance, fluorescence, CD, and FTIR 
spectroscopies have been used extensively to monitor protein structural changes. 
However, the amount o f  secondary structure information obtainable in CD and FTIR
3
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spectroscopies is limited by complete absorbance o f  the signal by the denaturant in the 
spectral region o f  interest (Chen et al. 1998; Chen et al. 1999; Johnson 1990; Surewicz et 
al. 1993). Protein unfolding experiments using CD spectroscopy and the denaturant 
guanidine hydrochloride (GdnHCl) are limited to wavelengths above 210 nm because o f  
significant absorption by the denaturant. This limits the amount o f  structural information 
that can be gained using CD because wavelengths down to 178 nm must be used to make 
accurate estimates o f  protein secondary structure (Johnson 1990). Unfolding experiments 
monitored by FTIR spectroscopy are also limited because water and the denaturant 
GdnHCl absorb strongly (peak centers o f  1645 and 1673 cm'1, respectively) across the 
entire amide I region (1600-1700 cm'1) which is the region relevant to secondary 
structure. While D 2 O can be used to make non-denaturing aqueous studies more feasible 
(Byler and Susi 1986; Castresana et al. 1988; Surewicz and Mantsch 1988), there are 
currently few  accurate methods for studying proteins in solutions containing high 
denaturant concentrations. Since folding intermediates have been implicated in protein 
folding diseases such as transmissible spongiform encephalopathies, Parkinson's, 
Huntington's, and Alzheimer’s disease (Maiti and Surewicz 2001; Swietnicki et al. 2000; 
Taubes 1996), improving methods to study unfolded protein structure could help 
elucidate the mechanisms associated with these diseases.
Cytochrome c (Cyt c) is a model protein for investigating protein structure and 
folding. The biological function o f  Cyt c involves shuttling electrons as part o f  energy 
transduction in mitochondria and it can exist in two oxidation states with the heme iron 
either in the Fe(III) (as in ferricytochrome c) or Fe(II) (as in ferrocytochrome c) oxidation
4
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states. This investigation uses Cyt c isolated from horse heart, which is made up o f  104 
amino acid residues and a covalently attached heme giving a molecular mass o f  12,384 
Da (from this point forward all mention o f  Cyt c  refers to ferricytochrome c). Figure 1 
shows a schematic diagram o f  Cyt c  from X-ray diffraction coordinates (Bushnell et al. 
1990) with structural elements o f  interest highlighted. Overall, Cyt c  is composed o f  three 
major and two minor helical elements interconnected by strands o f  polypeptide chain 
folded into a roughly spherical shape within which the heme pocket resides. The specific 
secondary structural elements within the protein include five a-helices (residues 6 to 14, 
49 to 54, 60 to 69, 70 to 75, and 87 to 102), a short two-stranded anti-parallel P-sheet 
(residues 37 to 40 and 57 to 59), and six P-tums (residues 14 to 17, 21 to 24, 32 to 35, 35 
to 38, 67 to 70, and 75 to 78). The heme prosthetic group is covalently attached to two 
cysteine residues at positions 14 and 17 by thioether bonds. The heme iron is coordinated 
by two ligands, a histidine at position 18 and a methionine at position 80.
The structure and folding o f  Cyt c  have been well characterized because o f  its small size 
which makes structural interpretation easier, it is easy to purify, has a reversible folding 
transition, has excellent spectroscopic properties, and is well behaved in aqueous 
solution. Its structure and folding have been well characterized using various 
spectroscopic techniques including fluorescence (Tsong 1973; Tsong 1974; Tsong 1975; 
Tsong 1976), visible absorption (Myer 1984; Sreenthan and Taylor 1971), CD (Hamada 
et al. 1994), NMR (Feng et al. 1990; Qi et al. 1996; Roder et al. 1988), X-ray diffraction 
(Bushnell et al. 1990), and FTIR (Bowler et al. 1994; Byler and Susi 1986; de Jongh et
5
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al. 1995; Dong et a l  1990; Emst-Fonberg et al. 1993; Filosa et al. 1999; Goormaghtigh 
et al. 1990; Oberg and Fink 1998).
In previous unfolding studies using fluorescence and CD spectroscopies, Cyt c 
has been shown to unfold in a two-step process from a native folded structure to a non­
native, unfolded structure. It was shown previously by Tsong that the tryptophan 59 
(Trp59) fluorescence o f  Cyt c is sensitive to overall protein conformation. A major 
structural transition can be monitored by fluorescence because in its native conformation 
the indole ring o f  the single Trp residue in Cyt c donates a hydrogen bond to the heme 
prosthetic group, resulting in the complete quenching o f  the Trp fluorescence by Forster 
energy transfer to the heme. Upon denaturation, the Trp59 indole ring hydrogen bond to 
the heme is lost as the protein unfolds, resulting in a decrease in quenching by the heme 
and, therefore, a stronger fluorescence signal (Rush and Spiro 1998; Tsong 1976). Tsong 
reported that a major Cyt c structural transition occurs from 2.5 to 3.5 M GdnHCl at pH
7.0 with a transition midpoint (Tm) at 2.7 M GdnHCl. Tsong also reported that certain 
residual structures o f the protein are retained, as judged by the change in Trp59 
fluorescence, after the major conformational transition is over (Tsong 1974; Tsong 1975; 
Tsong 1976).
Circular dichroism has also been used to monitor the changes in secondary 
structure o f  equilibrium unfolded Cyt c. Being a highly a-helical protein in its native state 
(Figure 1), Cyt c  correspondingly has an a-helical CD spectrum at low denaturant 
concentrations (< 2 M GdnHCl). Hamada and coworkers reported that as the GdnHCl 
concentration is increased, Cyt c  follows a cooperative, two-state equilibrium unfolding
7
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transition with no a-helix component present above 3.5 M GdnHCl (Hamada et al.
1996). The midpoint o f  the unfolding transition was identical to the fluorescence 
monitored transition midpoint at 2.7 M GdnHCl.
While the fluorescence and CD unfolding experiments suggest a two-state 
unfolding process other equilibrium folding studies o f  Cyt c have shown that the folding 
is not entirely a two-state process. Rush and Spiro have shown using resonance Raman 
spectroscopy that at pH 7.0 the transition midpoints for the loss o f  tyrosine hydrogen 
bonds present in the native structure occur at slightly lower denaturant concentrations 
(-2 .5  M) than the transition midpoints for tryptophan fluorescence and CD unfolding 
experiments (2.7 M) (Rush and Spiro 1998). Using small angle X-ray scattering to 
monitor radii o f  gyration o f  the GdnHCl equilibrium unfolded species o f  Cyt c, Segel and 
coworkers reported that Cyt c  has an unfolded intermediate and is likely to have a 
number o f  denatured state populations (Segel et al. 1998).
Results from other experiments monitoring equilibrium unfolding o f Cyt c also 
suggest Cyt c unfolding is not a two-state process. The absorption band o f  Cyt c  at 695 
nm was shown to be due to the binding o f  the sulphur contained in the methionine 80 
(Met80) side chain to the heme iron (Dickerson et al. 1967; Schechter and Saludjian 
1967) and has been used to monitor the conformational state o f  Cyt c (Schjeter and 
George 1964; Sreenthan and Taylor 1971). The Fe(III)-»Met80 coordination was shown 
to be essentially gone at GdnHCl concentrations above 3.0M at pH 7.0, suggesting a 
slightly lower transition midpoint for the conformational change than reported for the 
fluorescence and CD experiments described above (Ferri et al. 1996; Sreenthan and
8
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Taylor 1971). In addition, results from experiments where equilibrium unfolded Cyt c 
samples were monitored by cyclic voltammetry suggested the presence o f  intermediate 
Cyt c  structures at GdnHCl concentrations between 1.0 and 4.0 M (Ferri et al. 1996). 
Time-resolved studies o f  Cyt c folding using fluorescence, CD and FTIR spectroscopies 
also indicate that multiple structures occur along the folding pathway (Englander et al. 
1998; Roder et al. 1988; Shastry et al. 1998; Telford et al. 1998; Yeh et al. 1998).
In the case o f  structural investigations o f  equilibrium unfolded Cyt c using FTIR 
spectroscopy, Bowler and coworkers reported an improved method to study the states o f  
GdnHCl denatured proteins (Bowler et al. 1994). They showed that the spectral 
contributions from up to 3.0 M GdnHCl could be reliably subtracted from the 
experimental spectrum o f  Cyt c  allowing for a qualitative comparison o f  the denatured 
state protein spectra. They reported that structural changes monitored by second 
derivative Fourier-transform infrared spectroscopy analysis start at 1.5 M GdnHCl. 
Saturation o f  the Hg/Te/Cd detector at the cell path length they used (6 pm) limited the 
concentration o f  GdnHCl to 3.0 M. Thus to date, the highest GdnHCl concentration 
reported for studying equilibrium unfolded Cyt c using FTIR is 3.0 M GdnHCl (Bowler 
et al. 1994). Considering that fluorescence (Tsong 1974), CD (Hamada et al. 1996), 
absorbance (Ferri et al. 1996; Sreenthan and Taylor 1971), X-ray scattering (Segel et al.
1998), and cyclic voltammetry (Ferri et al. 1996) Cyt c unfolding experiments have 
shown that transitions occur anywhere from 2.0 to 6.0 M GdnHCl. The FTIR limit at 
3.0M GdnHCl does not allow for the complete observation o f  the unfolding transition, 
nor does it allow for the observation o f  proteins in more fully denaturing concentrations
9
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o f GdnHCl (~6.0 M GdnHCl). An improved method for studying denatured proteins in 
higher concentrations o f  GdnHCl using FTIR spectroscopy is therefore desirable.
There have recently been two reports describing methods that improve FTIR 
monitoring o f  protein denaturation at high denaturant concentrations. Oberg and Fink 
demonstrated using attenuated total reflectance Fourier-transform infrared (ATR-FTIR) 
spectroscopy that spectra could be obtained at 6 M GdnHCl concentrations that were well 
within the linear range o f  the instrument (Oberg and Fink 1998). In addition, Fabian and 
Mantsch showed that infrared detector saturation in the amide I region resulting from 
high urea concentrations could be reduced using carbon-13 labeled urea which causes the 
carbonyl band o f  urea to shift out o f  the amide I region (Fabian and Mantsch 1995). 
Results from experiments that used the high sensitivity o f  ATR-FTIR spectroscopy and 
isotope labeling o f  the denaturant in order to develop an improved method for studying 
the denatured structures o f  Cyt c  are described (Speare and Rush 2003). We have 
obtained amide I infrared spectra o f  horse heart Cyt c  in the presence o f  deuterium 
substituted GdnHCl (DGdnHCl) using ATR-FTIR spectroscopy. We show that the 
substitution o f  all exchangeable protons in GdnHCl with deuterium shifts the C=N 
vibrational peak o f  GdnHCl, thereby minimizing the distortion o f  the amide I region by 
the denaturant. Changes in secondary structure o f  equilibrium unfolded Cyt c, monitored 
from 0 to 6.6 M DGdnHCl and 0 to 6.7 M GdnHCl, were investigated.
Together, the investigations o f  equilibrium unfolding o f  Cyt c  described above 
strongly indicate that Cyt c unfolding is not a two-state transition. None o f  the previous 
investigations o f  the structural changes that Cyt c undergoes during equilibrium
10
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unfolding have been performed using the various probes together in a systematic and 
even-handed way. It is the purpose o f  this investigation to better characterize the various 
conformational states o f  horse heart Cyt c  at equilibrium denatured in GdnHCl under 
equivalent experimental conditions (e.g., protein type, pH, buffer). In order to accomplish 
this task, coinciding equilibrium unfolding experiments were performed using 
fluorescence, CD, ATR-FTIR, and visible absorption spectroscopies. Results indicate that 
equilibrium unfolding o f  Cyt c is not a two-state transition.
B . E x p e r im e n t a l  M e t h o d s
1. M aterials— Cyt c  from horse heart was obtained from Sigma (C-7752, >99% purity, 
molecular mass 12,384 Daltons [Da]). Deuterium oxide (D20 )  was obtained from 
Cambridge Isotope Laboratories (DLM-4, 99.9% purity). All water used for sample 
preparation was purified to 18.0 megohm-cm resistivity. All buffer solutions were filtered 
using Millex-GV 0.22 pm Durapore™ (PVDF) filters.
2. Preparation o f  Cytochrome c Sam ples fo r  Fluorescence, Absorbance, and Circular
Dichroism Spectroscopy— Horse heart Cytochrome c (molecular mass 12,384 Da), from
Sigma, was used without further purification. A  1.0 mM stock solution o f  Cyt c was
prepared in 0.01 M sodium phosphate buffer at pH 7.0. The concentration was confirmed
using the absorbance at 526.5 nm which is an isosbestic point (extinction coefficient =
11,000 /M cm) where ferricytochrome c  and ferrocytochrome c  have identical extinction
11
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coefficients. An absorbance measurement was performed to determine the oxidation state 
by measuring from 350 to 650 nm to confirm complete oxidation to ferricytochrome c. A 
broad peak from 500 to 600 nm is characteristic o f  ferricytochrome c, whereas two 
sharper peaks at 520 and 550 nm are characteristic o f  ferrocytochrome c.
Stock solutions (0.0 to 7.0 M by increments o f  0.5 M) o f  guanidine hydrochloride 
in 0.01 M sodium phosphate buffer at pH 7.0 were prepared in the following manner: The 
appropriate amount o f  guanidine hydrochloride was weighed out and placed in a 100 mL 
volumetric flask along with 6.1 mmoles o f  Na2HPC>4 and 3.9 mmoles ofN aH 2PC>4 . The 
mixture was then diluted to 100 mL with H2 O. The pH o f  each solution was adjusted to
7.0 if  necessary using NaOH or HC1. The GdnHCl concentrations o f  each solution were 
checked using an Abbe type refractometer. Concentrations in molarity were calculated 
using the following equation:
[GdnHCl] = 57.147(AN) + 38.68(AN)2 -91 .60(A N )3
Equation 1
where AN is the difference between the refractive index o f  the GdnHCl solution and 
water (T^Oydeuterium oxide (D2 O) at the sodium D line (Nozaki 1972).
Using the stock guanidine hydrochloride solutions prepared as described above,
3.0 mL o f  each the 15 solutions was placed into individual vials. 45 pL o f  the 1.0 mM 
Cyt c solution prepared as described above was placed into each vial and mixed carefully. 
The resulting 15 pM Cyt c  denaturant solutions were allowed to stand for 1 hour 
maximum before recording the fluorescence, absorbance, and CD spectra.
12
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3. Tryptophan Fluorescence Spectroscopy— The fluorescence spectra for the Cyt c 
solutions were obtained at an excitation wavelength o f  280 nm using a Shimadzu RF- 
1501 Spectrofluorophotometer with PC 1501 software. The emission was recorded from 
250 to 500 nm for all samples. The folding titration curves were prepared using 
Microsoft Excel. The fraction unfolded was determined using the signal change at 350 
nm and was calculated using the following equation:
f [(Sample Intensity at 350 n m )- (O.OM GdnHCl Sample Intensity at 350 nm)] 1x100
[[(7.0M GdnHCl Sample Intensity at 350 n m )- (0.0M GdnHCl Sample Intensity at 350 nm)]J
Equation 2
The values obtained, using the equation above, were plotted against the corresponding 
concentrations guanidine hydrochloride to obtain the folding titration curve.
4. Absorbance Spectroscopy—The absorbance spectra for each o f  the 15 pM cytochrome 
c solutions used in the fluorescence experiments were recorded from 350 to 750 nm using 
a Perkin-Elmer Lambda 11 UV/Vis Spectrometer with UV Winlab software. Peak-fitting 
at 695 nm was performed using the curvefit macro on Galactic Grams32 software. The 
resulting peak intensities were recorded and plotted versus the concentration o f  guanidine 
hydrochloride on Excel.
5. Circular Dichroism Spectroscopy—Circular Dichroism spectroscopy was performed 
using an On-Line Instrument Systems Inc. (OLIS) CD module with Cary-16 
Spectrophotometer Conversion Unit with accompanying OLIS Software. Instrument
13
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calibration was performed using camphorsulfonic acid. Samples were scanned in a
1.0 mm cylindrical cell from 260 to 200 nm with a 0.5 nm scanning interval. Protein 
unfolding was monitored using the ellipticity at 222 nm after subtraction o f  spectral 
contributions due to buffer and denaturant (Hamada et al. 1996).
6. Unfolding Curve Analysis— Unfolding curves were analyzed using methods described 
by other investigators (Hamada et al. 1996; Pace 1986; Pace and Scholtz 1997) The 
folding was assumed to be a two-state transition from the native state (N) to the 
denatured state (D) where the free energy change o f  unfolding (AG) is defined as:
AG = -RTlnKu
Equation 3
Where R is the molar gas constant, T is the temperature in Kelvin, and Ku is the 
equilibrium constant for the unfolding transition obtained using the equation:
^  ( [* ] - [£ ]* )
mD-m
Equation 4
Where [0], [0]N and [0]D are the spectroscopic signals for the sample, and the native and 
denatured states respectively. The unfolding transition curves were analyzed by plotting 
AG for samples in the transition region versus the denaturant (GdnHCl) concentration. 
Assuming a linear dependence, the relationship o f  AG to GdnHCl concentration is 
described by the equation:
14
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
AG = AG(H20 )  - mfGdnHCI]
Equation 5
Where AG(H20) is the free energy o f  the protein in the absence o f  GdnHCl, [GdnHCl] is 
the concentration o f  GdnHCl in m oles per liter, and m is the slope, which is indicative o f  
the cooperativity o f  the transition (Pace 1986; Pace and Scholtz 1997).
7. Preparation o f  Samples fo r  ATR-FTIR Spectroscopy—Denaturant solutions up to 7.0 
M GdnHCl/DGdnHCl were prepared from stock solutions o f  7.0 M GdnHCl/DGdnHCl 
in 0.1 M pH/pD 7.0 phosphate buffer. The pD o f  samples prepared in D 2O were 
determined using a pH meter with microelectrode as described by Glasoe and Long 
(Glasoe and Long 1960) using the following equation:
pD = pH + 0.40
Equation 6
All samples prepared in D 2 O were adjusted to pD 7.0 using NaOD or DC1. GdnHCl and 
DGdnHCl concentrations were determined in moles per liter using refractometry as 
described above.
Deuterated guanidine hydrochloride was obtained by dissolving guanidine 
hydrochloride in D 2O at a 33% weight to volume ratio. After a 24 hour incubation the 
solution was placed on a Rotovap at 55 °C under vacuum until dry followed by another 
24 hour incubation in D 2 O to insure complete deuteration. The sample was then placed 
under high vacuum to remove residual water vapor. The completion o f  the deuteration
15
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reaction was confirmed using FTIR where DGdnHCl has a C=N stretching mode at 
1598 cm'1 compared to 1673 cm'1 for GdnHCl.
Denaturant solutions o f  Cyt c were prepared containing 5% protein by weight (50 
mg/mL). To prepare denaturant solutions containing similar H2O content due to waters o f  
hydration from the protein, the denaturant solution was treated with 1.0 pL o f  0.1 M 
phosphate buffer per milligram protein used. The resulting solutions were allowed to 
stand a minimum o f  48 hours prior to spectroscopic analysis to allow complete H—»D 
exchange. HaO/GdnHCl protein solutions were prepared by dissolving Cyt c  in buffered 
GdnHCl stock solutions. These samples were allowed to incubate at least one hour prior 
to analysis.
8. ATR-FTIR Spectroscopy—ATR-FTIR scans were performed using a Perkin-Elmer 
System 2000 FT-IR with an Infrared Associates model MCT-NB detector, a Graseby 
Infrared DP-8000-1 preamplifier and a Spectra Tech diamond cell ATR attachment. The 
ATR attachment was continuously purged using a Whatman FTIR purge gas system. One 
thousand scans were collected for each sample from 2500 to 1000 cm'1 at 2 cm'1 
resolution and a 1 cm'1 scanning interval with Kaiser-Bessel apodization. The diamond 
cell background was subtracted from the spectra o f  all samples.
9. ATR-FTIR Data Analysis— All spectral manipulations were performed using Galactic 
Grams/32 software. The main buffer/denaturant and transient H 2O vapor background was 
subtracted from the sample spectrum by the method by Dong et al. (Dong et al. 1990).
16
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The buffer/denaturant spectra were first subtracted after multiplication by a subtraction 
factor, so that there were no negative lobes adjacent to the amide I spectrum above 1700 
cm'1. The transient water vapor background was then subtracted from the resulting 
spectrum, after multiplication by an adjustment factor, so that the region from 1800 to 
1700 cm'1 was free o f  spectral contributions from water vapor. The resulting protein 
spectrum was then baseline corrected. Second derivative spectra were obtained from the 
protein spectra using a third-degree polynomial function with a 9-point Savitsky-Golay 
smoothing function. Deconvolution o f  protein amide I spectra was performed using the 
Deconvolution application in Grams/32 based on the method developed by Griffiths and 
Pariente (Griffiths and Pariente 1986). Gamma factors were determined from the width o f  
the widest resolvable peak in the corresponding second derivative spectrum (Arrondo et 
al. 1993). During deconvolution the gamma factor was adjusted so that there were no 
negative side lobes on the amide I peak. The final deconvolved spectra were smoothed 
using a Bessel apodization function and baseline corrected. Deconvolved spectra were 
curve-fit using the Grams/32 Curve-fit application. Only peaks identified by second 
derivative analysis were used for initial curve-fitting efforts. A  linear baseline was used 
for the curve-fit calculations. Peak frequencies were initially fixed at the frequencies 
determined in the second derivative spectrum and limited to ±  1.0 cm'1. The widths for 
major peaks were initially set at 2.5 to 3.0 times the width o f  the second derivative peak 
(Arrondo et al. 1999). The remaining peak widths were initially set at 5 cm'1. Peak width 
iteration was limited to a range from 4 cm'1 to 30 cm'1 to aid in obtaining a reasonable fit. 
Peak intensities were initially set at 90% peak intensity at the assigned peak frequency for
17
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the major peaks and peaks at the wings. The remaining peaks were set to 50% intensity 
(Abbott et al. 1991). Intensity limits were set from 0 to the intensity o f  the spectrum at 
the respective frequency. Peaks were assumed to be o f  mixed Gaussian-Lorentzian shape 
and were initially fixed at 10% Lorentzian and limited between 0 and 100%. The 
subsequent iteration process was carried out by fixing the frequencies and allowing the 
peak widths, intensities and shapes to vary. Then, only peak frequencies were allowed to 
vary while the other parameters were held fixed. An acceptable fit was determined both 
by the program's statistical analysis, and by visual inspection. Secondary structure 
estimates were made by calculating the secondary structure band percentage o f  the total 
amide I region (1600-1700 cm'1) using the following frequency ranges: In H2 O -  1620- 
1645 cm"1, p-sheet; 1645-1652 cm"1, random; 1652-1662 cm'1, a-helix; 1662-1690 cm"1, 
turns; In D 2 O - 1613-1637 cm'1, p-sheet; 1637-1646 cm'1 random; 1646-1662 cm"1, a -  
helix; 1662-1682 cm'1, turns. These assignments for curve-fitting estimates o f  secondary 
structure were made based on those used by other investigators (Byler and Susi 1986; de 
Jongh et al. 1995; Dong et al. 1990; Emst-Fonberg et al. 1993; Filosa et al. 1999; 
Goormaghtigh et al. 1990).
C . R e s u l t s  a n d  D is c u s s io n
1. Cytochrome c Equilibrium M onitored by Fluorescence Spectroscopy— Fluorescence 
spectroscopy has been used to monitor the folded state o f  cytochrome c. When excited 
with 280 nm light, Trp59 fluoresces at 350 nm. In the folded state, the Trp59
18
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
fluorescence is completely absorbed or quenched by the proximal heme which absorbs 
heavily from 300 to 400 nm. In the unfolded state the Trp59-Heme distance is increased, 
reducing the quenching and resulting in a strong fluorescence signal (Tsong 1973; Tsong 
1974; Tsong 1975). Figure 2 shows the fluorescence spectra o f  cytochrome c in 0.0 to 7.0 
M GdnHCl buffered in 10 mM sodium phosphate at pH 7.0. The spectra show the 
characteristic increase in fluorescence intensity resulting from the Trp59 and Heme 
groups becoming further separated as the protein unfolds. The unfolding curve (Figure 3) 
showed a slight signal change occurring prior to 2.5 M GdnHCl, which could be due to a 
number o f  structural changes, most likely tertiary structure changes and loosening o f  the 
native structure to that resembling the molten globule type structure. The gross 
conformation change or unfolding occurs from 2.5 to 3.5 M GdnHCl, as indicated by the 
large increase in fluorescence intensity. This intensity change is indicative o f  gross 
conformation change as the protein unfolds to a less ordered, non-native structure. Above 
3.5 M the intensity continues to increase, although not as dramatically as the unfolding 
region from 2.5 to 3.5 M, indicating that the Trp59 and the heme continue to become 
farther apart. Tsong attributed this discrepancy to the possibility that unfolded Cyt c  does 
not exist in a truly random coil state (Tsong 1975).
Unfolding curve analysis using Equations 3, 4, and 5 gave thermodynamic values 
o f -24.9 kJ/mole for the Gibbs free energy o f  conformation in the absence o f denaturant, 
a cooperativity o f  -7.97 kJ/mol/M, and a transition midpoint o f  2.7 M (Table 1). It is 
important to note that the transition point is pH sensitive, so every precaution was made 
to control the pH at 7.0 for all experiments (Tsong 1975).
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Thermodynamic
Parameter 695 nm Absorption Trp Fluorescence CD
Tm (M GdnHCl) 2.4 2.7 2.7
AG(H20 )  (kJ/mole)
m (cooperativity) 
(kJ/mole M)
-33.7
-14.3
-24.9
- 8.0
-34.7
-13.0
Table 1. Summary o f  Cyt c thermodynamic data from absorption, CD, and fluorescence
unfolding studies.
2. Cytochrome c Unfolding M onitored by Circular Dichroism Spectroscopy— The 
chemical unfolding o f  Cyt c using GdnHCl was monitored by CD spectroscopy. CD 
spectroscopy is useful for determining the major secondary structural components in a 
protein (Johnson 1990). Far-UV CD (185-250 nm) observes amide chromophore n—»ji* 
and n—Mi electronic transitions. In a protein, interactions between amide portions o f  
peptide bonds associated with 2° and 3° structure correlate to differences in the 
absorption o f  circularly polarized light. Spectral components associated with secondary 
structure have been assigned to 195 nm and 217 nm for random coil, 196 nm and 215 nm 
for p-sheet and 191, 208 and 222 nm for a-helix (Johnson 1999). In order to get accurate 
estimates o f secondary structure using standard CD basis sets it is necessary to obtain 
sample spectra down to 178 nm (Johnson 1990; Johnson 1999). The technique is limited 
in that a precise determination o f  the relative amounts o f  secondary structure is difficult 
in the presence o f  denaturants (e.g. guanidine hydrochloride) which absorb strongly in the 
UV region making spectral determinations below 210 nm impossible. However, for
22
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cytochrome c the a-helix content has been monitored using the ellipticity at 222 nm 
(Goto et al. 1993). Plotting the ellipticity at 222 nm versus the concentration of  
denaturant provides an unfolding titration curve in the same manner as the unfolding 
curve was determined using the fluorescence signal at 350 nm.
Figure 4 shows the CD spectra o f  the native protein and selected spectra from the 
analysis o f  GdnHCl induced unfolding. The native Cyt c  CD spectrum is typical for an a -  
helical protein with ellipticity minima at 222 and 208 nm and is consistent with what has 
previously been observed (Goto et al. 1993; Hamada et al. 1996). As denaturant is added, 
the spectrum gradually increases in ellipticity indicating a loss o f  a-helical structure. A  
plot o f  the ellipticity at 222 nm versus the concentration o f denaturant provides an 
unfolding titration curve (Figure 5) (Bowler et al. 1993; Goto et al. 1993; Hamada et al. 
1996). The transition midpoint o f  2.7 M GdnHCl is consistent with previously reported 
results (Goto et al. 1993). The Gibbs free energy in the absence o f  denaturant and 
cooperativity were calculated as -34.7 kJ/mole and -13.0 kJ/mole M respectively 
(Table 1).
3. Cytochrome c Unfolding M onitored hy Absorption Spectroscopy a t 695 nm— Visible 
absorption spectroscopy can be used to monitor the M et80-Heme coordination. The peak 
at 695 nm, present in absorption spectra o f  native Cyt c resulting from the coordination o f  
Met80 with the heme iron (Kaminsky et al. 1973; Sreenthan and Taylor 1971), was 
monitored at various denaturant concentrations to determine the point at which the 
coordination was lost. Figure 6 shows that the peak was present in native Cyt c  and at low
23
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GdnHCl concentrations. At GdnHCl concentrations above 3.0 M the peak was no longer 
present. An unfolding curve was prepared by plotting peak area versus denaturant 
concentration to analyze the transition. Figure 7 shows that the change in peak area at 695 
nm is essentially complete at 3.0 M GdnHCl. Analysis o f the unfolding curve yielded a 
Gibbs free energy o f conformation in the absence o f  denaturant o f  -33.7 kJ/mole, a 
cooperativity o f -14.3 kJ/mole M, and a transition midpoint o f  2.4 M (Table 1). While the 
Gibbs free energies and cooperativities are comparable, the transition midpoint value 
suggests that the loss o f  the iron-Met80 coordination occurs earlier in the unfolding o f  the 
protein relative to the changes in secondary structure monitored by CD and the Trp59- 
Heme distance changes monitored by fluorescence.
4. Cytochrome c unfolding m onitored by ATR-FTIR Spectroscopy— Attenuated total 
reflectance (ATR) FTIR has been used extensively to determine relative amounts o f  
secondary structure in proteins (Arrondo et al. 1993; Byler and Susi 1986; Surewicz et al. 
1993). The carbonyl stretch vibrations o f  protein backbone carbonyl groups give rise to 
absorption in the amide I region from 1600-1700 cm'1. The energy o f  this vibration is 
highly sensitive to hydrogen bonding associated with secondary structure. It is possible to 
estimate amounts o f  secondary structure using band-narrowing methods such as second 
derivatives and Fourier deconvolution to resolve individual vibrational contributions. The 
individual bands can then be quantified using curve-fitting analysis. In addition, unlike 
CD spectroscopy, proteins denatured by chemical denaturants (e.g., guanidine 
hydrochloride) can be monitored. Spectral contributions by the denaturant can be
26
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subtracted so as not to distort the protein spectral contributions (Dong et al. 1990). In this 
study D 2O is used to allow for the deuteration o f  the denaturant guanidine hydrochloride. 
Guanidine hydrochloride has a C=N stretching mode at 1675 cm'1 that overlaps the 
protein amide I region interfering with spectral subtraction. Deuterated guanidine 
hydrochloride has a C=N stretching vibration shifted to the lower wavenumber portion o f  
the amide I region at 1600 cm'1. This allows the view o f  the main portion o f  the amide I 
region containing the bulk o f  the secondary structure o f  Cyt c  with less overlap o f  the 
denaturant band. Equilibrium unfolded solutions o f  Cyt c were analyzed using ATR- 
FTIR with deuterated GdnHCl to gain a higher resolution viewpoint o f  conformational 
differences between equilibrium-unfolded solutions o f  Cyt c  in DGdnHCl. A comparison 
was made to spectra o f  denatured Cyt c  in H2O to show that spectra o f  Cyt c in DGdnHCl 
have less amide I region distortion after denaturant spectral subtraction than spectra o f  
Cyt c in GdnHCl.
The advantages o f  using deuterated GdnHCl are shown clearly in Figures 8a and 
8b, which show representative spectra o f  native Cyt c  and deuterated Cyt c  (DCyt c) 
overlapped with the corresponding denaturant spectrum (GdnHCl or DGdnHCl). Natural 
abundance GdnHCl has a normal mode vibration at 1671 cm'1 primarily due to the stretch 
o f the C=N bond. The same normal mode in DGdnHCl is shifted to lower energy at 1598 
cm'1 indicative o f  deuterium substitution and consistent with ab initio calculations 
(Chakraborty and Manogaran 1994). The complete deuteration o f GdnHCl was obtained 
by incubating GdnHCl in D2 O at a 33% weight to volume ratio for 24 hours with one 
solvent exchange. Figure 9 shows that after these two incubation periods, the GdnHCl is
27
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completely deuterated judging by the fact that the peak does not red-shift further after an 
additional solvent exchange. The red-shift in absorption in the DGdnHCl denaturant 
spectrum significantly lessens the amount o f  overlap with the protein vibrations as 
compared to the non-deuterated sample thereby improving the sensitivity o f  methods to 
obtain the spectrum due to protein alone.
We explored the effects o f  over- and under-subtraction o f  the GdnHCl (Figure 
10a) and DGdnHCl (Figure 10b) solution spectra in the amide I region following the 
procedure o f  Bowler et al. (Bowler et al. 1994). To obtain a protein amide I spectrum, the 
background buffer and denaturant (if  applicable) spectrum must be subtracted from the 
corresponding protein spectrum. Before subtracting, the denaturant/buffer spectrum is 
multiplied by a subtraction factor to ensure that the resulting amide I spectrum is not 
over- or under-subtracted. Whether subtracting GdnHCl or DGdnHCl, care must be taken 
to avoid using an incorrect subtraction factor. Incorrect subtraction would result in a 
distorted amide I spectrum and may therefore lead to erroneous secondary structure 
interpretations. In Figure 10a, for the GdnHCl subtraction process, it can be seen that 
over- and under-subtraction lead to differences in intensity and slight differences in peak 
position throughout the entire amide I region. Over- and under-subtraction o f  DGdnHCl, 
on the other hand, only shows slight intensity differences in the amide I region below  
1640 cm'1 (Figure 10b). Little to no effect is seen above 1640 cm'1. The adverse effects o f  
poor subtraction are increased the closer you get to 1598 cm'1, the vibrational frequency 
o f the deuterated guanidinium C=N normal mode. The most pronounced effect is at 1617 
cm'1, where the second derivative peak becomes more negative and shifts to lower
30
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frequency on over-subtraction. The changes however, are consistent with those reported 
by Bowler et al. who concluded that they are not significant enough to cause artifacts 
leading to poor spectral interpretation on a qualitative level (Bowler et al. 1994). While 
the effects o f over- and under-subtraction were demonstrated on the spectra o f  the highest 
denaturant concentrations it serves as proof o f  higher spectral integrity for samples in 
D 2O with any concentration o f  DGdnHCl compared to samples in H2O and GdnHCl.
To test the utility o f  this new method, the secondary structure o f  equilibrium mixtures o f  
DCyt c  and DGdnHCl were investigated by ATR-FTIR spectroscopy with second 
derivative analysis and amide I curve-fitting. Figure 1 la  shows the experimentally 
obtained amide I spectrum o f native DCyt c  with the atmospheric water vapor and solvent 
spectra subtracted (0.1 M phosphate buffer, pD 7.0). The inset shows the corresponding 
second derivative spectrum identifying individual bands in the amide I region used for 
curve-fitting. The second derivative spectrum o f native DCyt c  shows four major peaks, 
at 1674, 1653, 1636 and 1615 cm'1, which have been previously assigned to turns, a -  
helix, P-sheet, and P-sheet respectively (Figure 1 la  inset and 12b) (Byler and Susi 1986; 
Dong et al. 1990; Dong et al. 1995; Filosa et al. 1999; Muga et al. 1991b). Figure l ib  
shows the curve-fitting results for native DCyt c. Secondary structure estimates were 
determined to be 45% a-helix, 23% P-sheet, 13% turns and 19% random coil. These 
results are comparable to values reported by other investigators (Table 2) using IR 
spectroscopy (de Jongh et al. 1995; Dong et al. 1990; Filosa et al. 1999) and X-ray 
crystallography (Bushnell et al. 1990).
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M  GdnHCl
Am ide I Peak 
o f  Native Cyt c 
in H20
imO
I
 ! ( !---------------------------------------------------------
1750 1700 1650 1600 1550
Wavenumber (cm-1)
0.5 M  DGdnHCl
Amide I Peak o f  
Native DCyt c in 
D 20  \
im
O
I
 ( ! !----------------------------
1750 1700 1650 1600 1550
Wavenumber (cm-1)
Figure 8. ATR-FTIR spectra emphasizing the overlap between denaturant and 
protein bands, (a) 0.5 M guanidine hydrochloride and native Cyt c  in H20  with 
buffer and water vapor subtracted, (b) 0.5 M deuterated guanidine hydrochloride 
and native Cyt c in D20  with buffer and water vapor subtracted.
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In order to determine the secondary structure o f  DCyt c as it unfolds, samples 
were prepared in increasing concentrations o f  DGdnHCl and allowed to equilibrate prior 
to analysis by ATR-FTIR spectroscopy. As the denaturant concentration increases the 
amide I spectra change from having one main peak at 1650 cm"1 under native conditions 
to having two main peaks at 1618 and 1651 cm"1 under denaturing conditions (Figure 
12a). The amide I spectral changes are indicative o f  a cooperative two state process o f  
unfolding. To better resolve the structural changes second derivative spectra were 
obtained and overlaid for comparison (Figure 12b). The most abundant component o f  the 
secondary structure o f  native Cyt c is a-helix with lesser amounts o f  turns, random 
structure and P-sheet. Qualitatively, the changes in secondary structure o f  equilibrium 
solutions o f  DCyt c  with increasing concentrations o f  DGdnHCl, as monitored by second 
derivative spectra, reveal conformational changes where the content o f  a-helix decreases 
as p-sheet increases. The a-helix peak at 1653 cm"1 appeared from 0.0 to 2.9 M 
DGdnHCl. At 1.5 M DGdnHCl the peak distinctly shifted to 1650 cm"1 which is the 
wavenumber assigned to a-helical bands o f  proteins in D20  (Byler and Susi 1986). In a 
previous study a similar shift was seen in the amide I spectrum o f  thermally denatured 
DCyt c  (Muga et al. 1991b). Muga et al. attributed the shift to the exchange o f  interior 
amide protons o f  the helices as the overall structure o f  the protein changed from a 
compact native state to a more globular structure. Our findings are consistent with those 
o f Muga et al. in that these protons are not initially exchanged when the protein is in the 
folded state, resulting in an amide I band which is closer to the one expected for the
34
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protein in H2 O (1656 cm'1). The gradual decrease in size o f  the 1650 cm'1 peak over the 
1.9 to 2.9 M DGdnHCl range indicates a loss o f  helical structure. The disappearance o f  
the 1650 cm'1 peak at 3.4 M DGdnHCl is consistent with a-helix changes observed using 
CD spectroscopy (Hamada et al. 1996). The 1674 cm'1 peak associated with turns is not 
apparent above 3.4 M DGdnHCl. The broad peak at 1636 cm"1 associated with (3-sheet is 
not present above 1.0 M DGdnHCl. The 1615 cm"1 peak associated with p-sheet shifts to 
higher wavenumber and becomes the dominant peak above 2.6 M DGdnHCl indicating 
the protein has taken on a predominantly p-sheet structure.
To quantify the secondary structure o f  the denatured protein, curve-fitting was 
performed on the amide I spectra o f  DCyt c  up to 6.6 M DGdnHCl (Figure 13, Appendix 
I). Curve fitting was used to resolve amide I spectra into the multiple component bands 
which together make up the entire amide I spectra and correlate to the different types o f  
secondary structure. The component bands were used to quantify the amounts o f  
secondary structure present in the DCyt c samples. Table 3 shows the results o f  all curve- 
fitting quantification. One can see that as the denaturant concentration increases the 
amount o f a-helix decreases while the amount o f  P-sheet increases. The amount o f  turns 
and random structure essentially remain the same. Figure 13 shows the curve-fit 
performed on the deconvolved 6.6 M DCyt c spectrum (additional curvefits are shown in 
Appendix I). The spectrum has two main peaks, the dominant one at 1613 cm'1 indicating 
the protein has taken on more P-sheet secondary structure than the native protein. The 
amount o f  P-sheet in the 6.6 M DGdnHCl sample was estimated to be 51% compared to 
23% for the native protein (Tables 2 and 3). This result is surprising because one would
35
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Figure 10. ATR-FTIR spectra o f  (a) Cyt c in 6.7 M GdnHCl, 0.1 M phosphate buffer 
at pH 7.0 and (b) DCyt c in 6.6 M DGdnHCl, 0.1 M phosphate buffer at pD 7.0 
showing the effects o f  over- (lower spectrum) and under-subtraction (upper 
spectrum) o f  the respective denaturant spectrum. The insets show the second 
derivatives o f  the over- (upper spectrum) and under-subtracted (lower spectrum)
amide I spectra.
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Figure 11. (a) ATR-FTIR spectrum o f  native DCyt c , 0.1 M phosphate buffer, pD 
7.0. An inset o f  the second derivative in the amide I region (1700-1600 cm -1) is 
shown to demonstrate identification o f  component bands associated with secondary 
structure, (b) Curve-fit results for the deconvolved amide I band o f  native DCyt c in 
0.1 M phosphate buffer, pD 7.0. Areas o f  individual component bands are 
representative o f  the secondary structure o f  the protein. The spectrum labeled with 
“+” is the deconvolved amide I spectrum.
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Figure 12. (a) Stacked overlay o f  the amide I spectra o f  DCyt c 
(0.1 M phosphate buffer, pD 7.0) in the presence o f  increasing 
amounts o f  DGdnHCl. The molarity o f DGdnHCl for each 
spectrum is indicated on the right, (b) Second derivative amide I 
spectra o f  DCyt c in the presence o f  DGdnHCl. The molarity o f  
DGdnHCl for a given spectrum is as indicated by the arrows.
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M ethod Denaturant % a -  % 0- % % Reference
Concentration helix sheet Turns Random
ATR-
FTIR
0.0 M 
DGdnHCl 45 23 13
19 This
Study
ATR- 6.6 M
17 51 18 15
This
FTIR DGdnHCl Study
ATR-
FTIR 0.0 M GdnHCl 42 27 6 5
This
Study
ATR-
FTIR
6.7 M GdnHCl 0 93 1 6
This
Study
(Bushnell
X-ray 45 15 eta l.
1990)
Table 2. Comparison o f  Secondary Structure Estimates o f  native and denatured DCyt c  
and Cyt c  to X-ray diffraction estimate o f  native structure.
39
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
expect the protein to predominantly consist o f  more random structure at high denaturant 
concentrations rather than maintain ordered secondary structure. Previous IR studies o f  
thermally denatured (Dong et al. 1995; Muga et al. 1991b; Surewicz et al. 1990) and 
aggregated (Caughey et al. 1991b) proteins have attributed peaks below 1620 cm'1 to 
intermolecular P-sheet formation and aggregation. While aggregation is a possibility 
given the high protein concentration used in our investigation (50 mg/mL), visual 
examination o f  samples and gel filtration chromatography showed no evidence o f  
aggregation (data not shown). The P-sheet content did not appear to be concentration 
dependent given that the normalized amide I spectra o f  50, 25 and 10 mg/mL Cyt c  in 6.7 
M GdnHCl were identical (Figure 14). The high P-sheet content is also confirmed by the 
high amount o f  P-sheet (93%) determined for Cyt c denatured in 6.7 M GdnHCl (Table 2, 
Appendix I).
For a qualitative comparison o f  the changes seen with the samples in D 2 O and 
DGdnHCl, equilibrium solutions o f  Cyt c  in H2O and GdnHCl were analyzed by ATR- 
FTTR in the presence o f  0.0 to 6.7 M GdnHCl. While curve-fitting was not performed on 
all samples in the presence o f denaturant because the amide I region is less precisely 
determined due to problems with denaturant subtraction, the amide I and second 
derivative spectra are still useful for identifying secondary structure because the 
wavenumbers for peak centers are approximately correct (Figure 10a). Starting with the 
Cyt c/GdnHCl amide I and second derivative spectra in Figure 15a, one observes 4 major 
peaks for native Cyt c (0.0 M GdnHCl) at 1681, 1655, 1633 and 1615 cm'1. These peaks 
have been previously assigned to turns, a-helix, p-sheet at 1681,1655, and 1633 cm'1
40
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Figure 14. Dependence o f  Cyt c  amide I spectrum on concentration o f  Cyt c. 
Normalized (a) amide I spectra and (b) second derivative spectra o f  5% (black), 
2.5% (blue), and 1.0% (red) Cyt c  (weight:volume) in 6.7 M GdnHCl suggest that 
amide I spectrum is not influenced by concentration o f  Cyt c.
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[DGdnHCl]
(M)
% Helix % Beta Sheet % Turns % Random
0.0 45 23 13 19
1.0 39 49 10 2
1.5 43 39 11 7
2.3 34 46 11 10
2.4 34 56 10 0
2.5 29 57 13 1
2.6 17 41 9 33
3.4 17 39 17 27
3.8 15 49 14 22
4.5 15 49 15 22
5.2 20 56 12 12
6.6 17 51 18 15
Table 3. Curve-fitting results for amide IIR  spectra o f  DCyt c  denatured in DGdnHCl.
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respectively (Bowler et al. 1994; Byler and Susi 1986; Dong et al. 1990; Emst-Fonberg 
eta l. 1993; Filosa e ta l. 1999; Goorraaghtigh et al. 1990; Lee et al. 1990; Oberg and Fink 
1998). The 1615 cm'1 peak has been assigned to side chain interactions not associated 
with secondary structure (Susi and Byler 1983). The secondary structure o f native Cyt c 
was estimated by curve-fitting (Figure 15b) to be 42% a-helix, 27% P-sheet, 6% turns 
and 5% random coil (Table 2). These results are also comparable to FTIR results reported 
by other investigators (Dong et al. 1990; Emst-Fonberg et al. 1993; Filosa et al. 1999) 
and to X-ray diffraction estimates (Bushnell et al. 1990). Similar to the DCyt c  data, the 
stacked overlay o f  amide I spectra o f  Cyt c  in increasing concentrations o f  GdnHCl 
indicates a highly cooperative two-state equilibrium unfolding process (Figure 16a). With 
increasing denaturant concentrations the one main peak center shifts from 1652 cm'1 to 
1635 cm'1 indicating a shift from a-helical to p-sheet structure. Unlike the amide I 
spectra for DCyt c however, the Cyt c spectra have only one main peak at high denaturant 
concentrations. Following the second derivative spectra in Figure 7b the major peak at 
1655 cm'1 associated with a-helix is present from 0.0 to 2.6 M GdnHCl, and gradually 
shifts to 1653 cm'1 by 2.6 M GdnHCl; at 3.2 M GdnHCl the peak is no longer 
distinguishable indicating the loss o f  a-helix structure similar to the changes seen with 
DCyt c. This change in secondary structure is consistent with previous CD data (Hamada 
et al. 1996) and the overall unfolding o f  the protein as monitored by tryptophan 
fluorescence quenching (transition midpoint o f  2.7 M GdnHCl) (Tsong 1974). The 
increase in the size o f  the doublet peak at 1638 and 1644 cm'1 with up to 6.7 M GdnHCl 
indicates an increase in p-sheet similar to the increase seen in the DGdnHCl samples up
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to 6.6 M (51% p-sheet) with an estimated 93% o f  the structure consisting o f  p-sheet 
(Table 2, Appendix 1). The reason for the discrepancy between the amounts o f  P-sheet in 
the GdnHCl sample versus the DGdnHCl sample is not clear. It is possible that the high 
absorbance o f  GdnHCl in the in the amide I region leads to distortion o f  the protein 
spectrum after subtraction o f  the denaturant spectrum.
The observed increase in p-sheet for both Cyt c in 6.7 M GdnHCl and DCyt c  in
6.6 M DGdnHCl is, at first, surprising as proteins in the presence o f  GdnHCl have been 
previously shown to have the properties expected o f  random coil polypeptides (Creighton 
1990; Ikai et al. 1973). However, more recently it has been shown that denatured proteins 
consist o f a collection o f  partially folded states (Dill and Shortle 1991; Dobson et al.
1984; Griko et al. 1988; Howarth and Lian 1984; Privalov et al. 1989; Smith et al. 1996). 
In addition it has been pointed out that in a truly random coil polypeptide the energetics 
o f  the interactions between different parts o f  the polypeptide chain and the solvent must 
be exactly balanced and that this is highly unlikely given the broad range o f  chemical 
properties for the 20 amino acids (Creighton 1990). In the case o f  Cyt c, Kataoka et al. 
demonstrated using small-angle X-ray scattering that Cyt c in the presence o f  4 M 
GdnHCl at pH 2.0 had a radius o f  gyration o f  32.4 A, which is lower than that estimated 
for a truly random coil suggesting that the denatured state contains residual structure 
(Kataoka et al. 1993). Our results suggest that denatured Cyt c  contains residual native p- 
sheet and/or newly formed p-sheet.
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Figure 15. (a) ATR-FTIR spectrum o f  native Cyt c, 0.1 M phosphate buffer, pH 7.0. 
An inset o f  the second derivative in the Amide I region (1700-1600 cm'1) is shown to 
demonstrate identification o f  component bands associated with secondary structure.
(b) Curve-fit results for the deconvolved amide I band o f  native Cyt c in 0.1 M 
phosphate buffer, pH 7.0. Areas o f  individual component bands are representative o f  
the secondary structure o f  the protein. The spectrum labeled with “+” is the 
deconvolved amide I spectrum.
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Figure 16. (a) Stacked overlay o f  the amide I spectra o f  Cyt c (0.1 M 
phosphate buffer, pH 7.0) in the presence o f  increasing amounts o f  
GdnHCl. The molarity o f  GdnHCl for each spectrum is indicated on the 
right, (b) Second derivative amide I spectra o f  Cyt c in the presence o f  
GdnHCl. The molarity o f  GdnHCl for a given spectrum is as indicated
by the arrows.
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5. Discussion— The folding studies presented in this report suggest that there are 
multiple events occurring within the structure o f  Cyt c as it unfolds. The data do not 
support the presence o f  a simple, two-state equilibrium between the native and unfolded 
states. The structural changes monitored by each spectroscopic method used in this study 
are summarized in Figure 17. The difference between the transition midpoints for the 
absorbance data and the CD and fluorescence data suggest that the Fe(III)-Met80 
coordination is lost prior to the complete unfolding o f  the secondary structure and the 
movement o f  Trp59 beyond the distance required for complete quenching by the Heme.
In addition, the FTIR studies suggest that the a-helices loosen at denaturant 
concentrations below 1.5 M GdnHCl and that p-sheet content increases all the way up to 
the highest denaturant concentrations tested (6.7 M GdnHCl). The structural changes are 
summarized in Figure 17 as follows: Between 0.0 and 1.5 M GdnHCl there is a loosening 
o f the Fe(III)-Met80 coordination and the a  helices, along with an increase in p-sheet 
structure; between 1.5 and 3.5 M GdnHCl there is a major loss in a-helix, a complete loss 
o f the Fe(III)-Met80 coordination, and significant increases in the Trp59-Heme distance, 
P-sheet, random structure, and turns; between 3.5 and 7.0 M GdnHCl there is a slight 
continuation o f  the increase in the Trp59-Heme distance, a continued increase in P-sheet 
structure, and a decrease in random structure.
The results suggest that there are multiple unfolded states for the protein at 
equilibrium conditions. The multiple bonding interactions associated with the native 
structure o f  the protein vary in strengths as do all forms o f  bonds. It seems intuitively 
correct to assume that these interactions occur over a narrow range o f  denaturant
48
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concentrations since non-covalent interactions are low energy interactions. Slight changes 
in the solvent environment apparently induce continual slight changes in protein structure 
until a critical point is reached. Or is it a critical point? The fluorescence unfolding curve 
(Figure 3) is deceptive in the sense that the fluorescence change upon unfolding appears 
as a dramatic jump. The efficiency o f  the energy transfer for fluorescence quenching, and 
absorbance-probed interactions, such as the Fe(III)-Met80 coordination are reduced by 
the acceptor-donor/transition dipole interaction distances raised to the 6th power. Slight 
changes in these distances lead to exponentially dramatic changes in probe response. This 
is not to say that dramatic structural changes do not occur but caution should be used 
when interpreting results o f  conformational probes o f  protein structures at equilibrium. It 
has been proposed that the rapid folding o f  Cyt c  goes through a number o f  intermediate 
states before attaining native conformation (Ferri et al. 1996; Rush and Spiro 1998; Segel 
et al. 1998). The results o f  equilibrium studies support this proposal in the sense that 
there are differences in the denaturant concentrations at which native structural features 
change to non-native structure as monitored by fluorescence, CD, absorbance, and FTIR 
measurements. Slight changes in tertiary and secondary structure such as repositioning o f  
loops and turns, can happen at any point prior, during, and after major structural changes 
occur, such as hydrophobic expansion upon unfolding or collapse upon folding.
50
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
D. Conclusions
In this study, it has been shown that amide I spectra at high denaturant 
concentrations (up to 6.6 M DGdnHCl) obtained using ATR-FTIR spectroscopy and 
DGdnHCl are less distorted than spectra obtained using GdnHCl. Using this method, 
significant amide I spectral changes were observed during chemical unfolding o f horse 
heart Cyt c. These spectral changes have not previously been reported and are not entirely 
observable by other secondary structure techniques. Solutions o f  equilibrium unfolded 
Cyt c  in D 2O and DGdnHCl were obtained from 0.0 to 6.6 M DGdnHCl. Qualitative 
analysis o f  the unfolding o f  the protein monitored by second derivative analysis revealed 
the protein unfolds from a mainly a-helical to a primarily P-sheet protein. Similar 
changes were observed in the second derivative spectra o f  Cyt c in H2 O from 0.0 to 6.7 
M GdnHCl. The secondary structure o f  the denatured protein in 6.6 M DGdnHCl and 6.7 
M GdnHCl were estimated by curve-fit analysis to be 51% and 93% p-sheet respectively. 
While the reason for the discrepancy between the DGdnHCl and GdnHCl denatured 
protein secondary structure estimates is not clear, both methods suggest the denatured 
protein contains a substantial amount o f  secondary structure. This new method allows 
insights into secondary structure changes induced by DGdnHCl and should be applicable 
to many water-soluble proteins.
Combining the ATR-FTIR Cyt c unfolding data with the fluorescence, CD, and 
absorption data has provided a clear view  o f  the equilibrium unfolded structures 
populated by Cyt c. The unfolding can be divided into three distinct domains defined by
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denaturant concentration: low concentration unfolding events 1.5 M GdnHCl), mid­
range denaturant concentration events (between 1.5 and 3.5 M GdnHCl), and high 
concentration unfolding events (between 3.5 and 7.0 M GdnHCl). At low denaturant 
concentrations there is a slight decrease in the Fe(III)-Met80 coordination, a loosening o f  
a-helices, and an increase in p-sheet structure. Many o f  the structural changes occur 
within the mid-range GdnHCl concentrations. These changes include a significant 
decrease in a-helix, a complete loss o f  the Fe(III)-Met80 coordination, a dramatic 
increase in the Trp59-Heme distance, and increases in P-sheet, random structure, and 
turns. At high denaturant concentrations there is a slight continuation o f  the increase in 
the Trp59-Heme distance, a continued increase in P-sheet, and a decrease in random 
structure. The results described in this report demonstrate that equilibrium unfolding o f  
Cyt c  is not a simple two-state process, but rather, is comprised o f  multiple complex 
structural transitions. Thus in order to improve understanding o f  the forces that drive the 
folding o f  Cyt c  and the folding o f  proteins in general, more sophisticated assumptions o f  
protein folding pathways and improved methods o f  determining protein structure 
(structural intermediates in particular) must be developed.
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II. The Role of Helix 1 Aspartates in the Stability and Conversion of Prion
Protein
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A . I n t r o d u c t i o n
Transmissible spongiform encephalopathies (TSEs) or prion diseases are 
neurological disorders characterized by the accumulation o f  abnormal protease-resistant 
forms o f prion protein (PrP)-e.g., scrapie-associated PrP or protease resistant PrP (PrP- 
res)-in the central nervous system o f  diseased animals. TSE diseases include Creutzfeldt- 
Jakob disease, Gerstmann-Straussler-Scheinker syndrome and kuru in humans, scrapie in 
sheep, mice and hamsters, bovine spongiform encephalopathy in cattle, and chronic 
wasting disease in deer and elk. Although not yet fully understood, the accumulation o f  
PrP-res appears to lead to cerebral amyloidosis, dementia, motor dysfunction, and 
eventually death. However, PrP-res has been shown to accumulate as a result o f  the 
conversion o f  the normal, protease sensitive form o f  PrP (PrP-sen) which occurs as a 
post-translational process without any apparent requirement for covalent modifications 
(Caughey and Raymond 1991; Hope et al. 1986; Stahl et al. 1993).
Outside o f  its role in TSE diseases the normal biological function o f PrP has not 
been clearly determined. However, mice lacking PrP have been observed to have altered 
sleep patterns and circadian activity rhythms (Tobler et al. 1996; Tobler et al. 1997). 
Additional studies have suggested other roles for the protein including regulation o f  
copper levels (Brown 1999; Brown et al. 1997; Jackson et al. 2001; Homshaw et al. 
1995; Thackray et al. 2002; Viles et al. 1999; Waggoner et al. 2000), super oxide 
dismutase activity (Brown 1999), and signal transduction (Mouillet-Richard et al. 2000).
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While the normal biological function o f  PrP-sen remains in question, much has 
been learned about its biochemistry. The gene for PrP encodes for polypeptides o f  254 
amino acids (Basler et al. 1986; Locht et al. 1986). An N-terminal signal peptide o f  22 
amino acids is removed from these molecules during biosynthesis (Bolton et al. 1987; 
Hope et al. 1986; Turk et al. 1988), and an additional 23 amino acids are removed from 
the C-termini during glycosylphosphatidylinositol (GPI) addition at Ser 231 (Stahl et al. 
1990), resulting in a mature PrP polypeptide o f  210 residues. The secondary structure o f  
PrP-sen has been analyzed by CD and FTIR spectroscopies, revealing the secondary 
structure consists predominantly o f  a-helix with little p-sheet (Pan et al. 1993). 
Additional structural studies using nuclear magnetic resonance (NMR) have provided 
more detailed views o f  PrP-sen structure. The structure o f  PrP-sen as revealed by NMR  
spectroscopy (Figure 18) consists o f  a core domain (residues 125-228), containing 3 a -  
helices (helix 1, residues 144-154; helix 2, 172-193; helix 3, 200-227), two short anti­
parallel p-strands (residues 129-131 and 161-163), and a largely unstructured N-terminal 
domain (residues 23-119) (James et al. 1997; Liu et al. 1999). A disulfide bond between 
cysteine residues 179 and 214 in PrP forms a loop (Turk et al. 1988), which contains two 
consensus sites for asparagine-linked glycosylation at residues 181 and 197. Addition o f  
glycans at these sites generates unglycosylated, partially glycosylated, and fully 
glycosylated PrP glycoforms. Following translation o f  PrP by the ribosome, high 
mannose glycans are added to the protein in the endoplasmic reticulum which are 
subsequently converted to complex or hybrid glycans in the Golgi apparatus (Caughey et 
al. 1989). Approximately 60 individual oligosaccharide chain variants have been
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identified on PrP, demonstrating that the partially- and fully-glycosylated proteins are 
composed o f  numerous minor glycoforms (Rudd et al. 1999; Stimson et al. 1999). 
Following processing in the Golgi apparatus, PrP-sen is translocated to the cell surface 
and anchored to the plasma membrane by the transmembrane insertion o f  the GPI anchor 
(Caughey et al. 1989; Caughey et al. 1990; Stahl et al. 1987; Stahl et al. 1990). Once on 
the cell surface, PrP-sen has a half-life o f  three to six hours (Borchelt et al. 1990;
Caughey et al. 1989; Caughey and Raymond 1991) and most PrP appears to be degraded 
in non-acidic compartments bound by cholesterol-rich membranes (Taraboulos et al. 
1995). Investigations on the endocytosis o f  PrP-sen indicate that it cycles between the 
cell surface and an endocytic compartment with a transit time o f  approximately 60 min 
(Shyng et al. 1993).
The prion hypothesis proposes that an abnormal form o f  PrP, such as PrP-res, is in 
fact the TSE infectious agent (Prusiner 1998). The importance o f  PrP in TSEs was 
clearly shown in infectivity experiments performed with PrP knockout mice. Mice 
completely lacking PrP were completely protected against TSE disease, and their ability 
to propagate infectivity was eliminated (Bueler et al. 1993). In diseased animals PrP-res 
forms insoluble aggregates and is partially resistant to proteinase K (PK), which removes 
approximately 67 amino acid residues (6-7 kDa) from the N-terminus (Hope et al. 1986; 
Meyer et al. 1986; Oesch et al. 1985; Rubenstein et al. 1986). These differences in 
biophysical properties most likely reflect different conformations o f  the two protein 
isoforms. While NMR and optical spectroscopic data indicate that PrP-sen isolated from 
normal brain is highly a-helical (James et al. 1997; Liu et al. 1999; Pan et al. 1993),
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FTIR studies indicate PrP-res contains a large proportion o f [3-sheet secondaiy structure 
(Caughey et al. 1991c; Safar et al. 1993). The conversion o f  PrP-sen into PrP-res is likely 
to be the key event in the pathogenesis o f  TSE diseases. Although TSE diseases may be 
sporadic, genetic or infectious in origin, it is commonly argued that in each circumstance 
the disease propagates itself through a self-catalytic mechanism involving existing 
multimers o f  PrP-res. This idea is supported by experiments such as studies using the 
cell-free conversion reaction which show that PrP-res can induce the conversion o f PrP- 
sen into PrP-res-like aggregates in vitro (Caughey et al. 2001; Kocisko et al. 1994).
While much work has been done using such model systems, the precise molecular 
mechanism o f  the conversion between the normal and pathogenic forms o f  prion proteins 
remains poorly understood.
Currently, two theoretical models o f  PrP-res formation have been described: the 
heterodimer model (Prusiner 1998) and the nucleated polymerization model (Come et al. 
1993; Jarrett and Lansbury, Jr. 1993; Lansbury, Jr. and Caughey 1995). The heterodimer 
model proposes that a stable PrP-res monomer binds PrP-sen, forming a heterodimer. 
Once PrP-sen is bound, the PrP-res portion o f  the heterodimer catalyzes a conformational 
change in PrP-sen leading to the formation o f  a homodimer o f  PrP-res. The PrP-res 
homodimer then dissociates yielding two PrP-res monomers. This model requires that 
PrP-res is more stable thermodynamically than PrP-sen, that conversion o f  PrP-sen to 
PrP-res is rare unless catalyzed by a preexisting PrP-res template, and that the PrP-res 
homodimer tends to dissociate into monomers. According to the model, conversion also 
requires the assistance o f  a hypothetical, species-specific cofactor termed “protein X ”
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(Bolton and Bendheim 1988; Griffith 1967; Prusiner 1998). In the nucleated 
polymerization model, PrP-sen binds to a preexisting polymer o f  PrP-res and 
subsequently converts. According to this model, seeded polymerization and conversion o f  
multiple PrP-sen monomers is required in order to stabilize PrP-res enough to allow its 
accumulation to levels that have biological impacts. The spontaneous formation o f  PrP- 
res multimers that can seed the polymerization is rare because o f  the weakness o f  
monovalent interactions between PrP-sen molecules and/or the rarity o f  the conformers 
that polymerize. However, once formed, polymeric seeds are stabilized by multivalent 
interactions that give PrP-res its characteristic resistance to disaggregation and proteolytic 
degradation (Griffith 1967; Gajdusek 1988; Jarrett and Lansbury, Jr. 1993; Lansbury, Jr. 
and Caughey 1995).
According to the proposed theoretical models described above, PrP-res and PrP- 
sen are expected to interact directly in the course o f  TSE pathogenesis. Empirical 
evidence suggesting that PrP-sen and PrP-res specifically interact has been provided in 
studies using animals (Prusiner et al. 1990), and scrapie-infected tissue culture cells 
(Priola et a l  1994; Priola and Chesebro 1995). More directly, specific binding o f  PrP-res 
to PrP-sen has been observed in lysates or culture supernatants from [3 5 S]-methionine- 
labeled cells expressing soluble PrP-sen lacking the GPI (GPL) anchor (Horiuchi and 
Caughey 1999). Under these conditions (pH 6.0, 1% sarkosyl), only GPI' [3 5 S]PrP-sen 
bound, out o f  the many labeled proteins in the preparations. Work exploring the 
interaction and conversion o f PrP-sen species containing the GPI anchor did not detect 
conversion o f  the membrane-bound PrP-sen by exogenous PrP-res (Baron et al. 2002). It
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was, therefore, proposed by Baron and coworkers that membrane attachment o f  PrP-sen 
may limit accessibility to PrP-res or prevent the conformational conversion necessary for 
PrP-res formation. The inaccessibility may result from the PrP-res binding sites being 
located near the C-terminus o f  PrP-sen. These sites may be blocked by attachment to the 
membrane via the C-terminal GPI anchor (Horiuchi and Caughey 1999), or direct 
interactions between membrane surfaces and the PrP-sen polypeptide chain may block its 
access to PrP-res (Morillas et al. 1999; Sanghera and Pinheiro 2002), although data from 
recent cell-free conversion studies do not support this latter possibility (Baron and 
Caughey 2003).
As mentioned above, cell-free conversion reactions have provided only 
circumstantial proof o f  the protein-only hypothesis because the cell-free conversion 
generated PrP-res has yet to be shown to be infectious. This has resulted in questions 
regarding its use as a physiologically relevant model o f  conversion. There are a number 
o f  ways, however, in which cell-free conversion reflects the biology o f  TSE disease in 
vivo. Cell-free conversion reactions have demonstrated PrP sequence specificity between 
the PrP-sen and PrP-res that correlates with inter- and intra-species TSE transmissions in 
vivo, possibly reflecting a critical control point in interspecies TSE transmissions 
(Bossers et al. 1997; Bossers et al. 2000; Horiuchi et al. 2000; Kocisko et al. 1995; 
Raymond et al. 2000; Raymond et al. 1997). In addition, the strain specificity o f  the 
reaction products is consistent with in vivo PrP-res formation and provides a potential 
mechanism for TSE strain propagation by a protein-only mechanism (Bessen et al. 1995). 
When unfolded with GdnHCl, both the converting activity o f  PrP-res and its infectivity
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titer in animals decrease, suggesting the two parameters are directly related (Caughey et 
a l  1997). Finally, since the in vitro conversion reaction has been adapted to 
physiologically compatible conditions, this suggests that it can also occur in vivo (Baron 
et al. 2002; Bessen et al. 1997; DebBurman et al. 1997; Horiuchi and Caughey 1999; 
Wong eta l. 2001). Thus, the variety o f  observations on cell-free conversion studies 
warrants its use as a model for studying the conversion o f  PrP-sen to PrP-res.
A number o f  mechanistic details about the conversion o f  PrP-sen to PrP-res have 
been described in reports that used the cell-free conversion reaction. Generation of  
conversion product was shown to be dependent upon time and the concentrations o f  input 
PrP-res and PrP-sen in a complex and in a condition-dependent fashion (Caughey et al. 
1995; Horiuchi and Caughey 1999). Converting activity was distinctly associated with 
PrP-res polymers but not with soluble monomeric forms o f  PrP from disaggregated PrP- 
res (Caughey et al. 1995; Caughey et al. 1997). There was no detectable dissociation o f  
newly converted PrP-res which remained associated with the seed PrP-res aggregates and 
was not solublized without GdnHCl treatment (Bessen et al. 1997; Callahan et al. 2001). 
Analyses o f the kinetics o f  conversion provided evidence that the conversion process can 
be separated into two stages, an initial binding o f  PrP-sen to PrP-res, and then a slower 
conversion o f  the bound PrP-sen to PrP-res (Bessen et al. 1997; DebBurman et al. 1997; 
Horiuchi and Caughey 1999). Comparisons o f  conversion reactions containing GdnHCl 
(Kocisko et al. 1994) and reactions containing no GdnHCl and low amounts o f  detergent 
suggest that the binding and conversion o f  the latter reactions occur at earlier time 
intervals (Wong et al. 2001). Recently, Zou and Cashman found a stimulatory effect by
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pretreatment o f  brain PrP-sen with acid pH and GdnHCl followed by exposure to a low  
concentration o f  sodium dodecyl sulfate (SDS) which could generate PrP-sen that is more 
convertible to PrP-res (Zou and Cashman 2002). Collectively, the observations made on 
the cell-free conversion reactions described above, and the fundamental characteristic o f  
PrP-res to form amyloid fibril polymers, are consistent with the conversion mechanism 
following the nucleated polymerization mechanism.
More insights into the conversion mechanism have been gleaned from studies 
using anti-PrP antibodies, which have been used to begin mapping the surfaces on PrP- 
sen that are involved in its initial binding to PrP-res during cell-free conversion (Horiuchi 
and Caughey 1999). So far, out o f  a number o f  antibodies directed against regions 
throughout the PrP sequence, only antibodies directed against the C-terminus o f  mouse 
PrP (a 2 19-232 epitope) have inhibited binding and have resulted in conversion o f  PrP- 
sen to PrP-res. However, removal o f  the a 2 19-232 epitope from PrP-sen did not 
eliminate binding suggesting that it is not the epitope itself that is required, but residues 
close to it in space that are sterically hindered by antibody binding. Surfaces that are 
close to the epitope through space include the extended chain o f  residues (-119-140) 
close to helix 1, the loop o f  residues after helix 1 (-165  to 174) between the second 0- 
strand and the second a-helix, and helical residues (-206-223) in the third helix 
(Horiuchi and Caughey 1999).
The same regions identified in antibody inhibition studies have been recognized 
using peptide inhibition studies as regions o f  possible interaction between PrP-sen and 
PrP -res. Peptides corresponding to residues 119-136 (Chabry et al. 1999; Chabry et al.
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1998), 166-189, and 200-223 (Horiuchi et al. 2001) were shown to inhibit both binding 
and conversion reactions. Peptides corresponding to residues 109-141 and 90-145 can 
also form protease-resistant complexes with PrP-sen (Kaneko et al. 1997a; Kaneko et al. 
1995). Amino acid substitutions in these regions have been shown to affect PrP-res 
formation in scrapie-infected cells (Kaneko et al. 1997b). The ability o f  such mutants to 
inhibit PrP-res formation may be due to an ability to bind wild type PrP-res and, without 
converting themselves, to interfere with the binding and/or conversion o f  wild type PrP- 
sen as has been shown for heterologous PrP-sen molecules (Horiuchi et al. 2000; Priola 
eta l. 1994).
Several considerations (Morrissey and Shakhnovich 1999; Homemann and 
Glockshuber 1998; Kaneko et al. 1995; Swietnicki et al. 2000b) suggest that helix 1 
(residues 144-153) might be a site o f  interaction o f  PrP-sen and PrP-res, and that it plays 
a critical role in the initial stages o f  PrP-sen unfolding and conversion to PrP-res. 
Morrissey and Shakhnovich (Morrissey and Shakhnovich 1999) noted that helix 1 is 
unusually hydrophilic and lacking in non-covalent contacts with the remainder o f  the 
protein. They proposed that the stabilization o f  helix 1 is self-sustaining through the 
presence o f intra-helix electrostatic interactions such as the two properly phased aspartate 
(Asp)-arginine (Arg) pairs at positions 144-148 and 147-151 respectively within the 
helix, which form strong salt-bridges and stabilize the helical turns (Figure 18)
(Morrissey and Shakhnovich 1999). The directional ordering o f  the charges is expected to 
interact with the intrinsic dipole moment o f  the helix providing further stabilization. 
Molecular modeling studies suggested that the conserved amino acid sequence o f  hamster
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PrP helix 1 (Table 4) might favorably adopt conformations necessary to form 
intermolecular P-sheet aggregates and that these aggregates might be stabilized by 
intermolecular salt bridges between the helix 1 Asp and Arg residues o f  adjacent 
molecules (Morrissey and Shakhnovich 1999). Consistent with this idea, Vorberg et al. 
reported that the deletion o f  helix 1 resulted in the complete inhibition o f  PrP-res 
formation in cell-free conversion reactions and scrapie infected cells (Vorberg et al.
2001). Other studies have shown that a de novo a-helix to p-sheet conformational change 
and aggregation o f  recombinant human PrP occurs in the presence o f  1 M guanidine 
hydrochloride and at pH’s below 5.0 (Homemann and Glockshuber 1998; Kaneko et al. 
1995; Swietnicki et al. 2000b). If the non-ionic denaturant urea was used, then the 
conversion to P-sheet also required NaCl. It is possible that the protonation o f  D 144 and 
D 147 at low pH interrupts the salt bridges in helix 1, and compromises its stability. The 
presence o f  the additional denaturant and salts may also help disrupt the overall structure 
and stability o f  the folded protein, and screen electrostatic charges that stabilize helix 1 .
To address the question o f  the role o f  helix 1 Asp residues and their salt bridges to 
Arg residues in the stabilization o f  PrP-sen and its conversion to PrP-res, six mutants 
replacing D144 and D147 with either asparagines or alanines were prepared to eliminate 
the putative salt bridges. The results indicate that PrP-sen is not substantially stabilized 
overall by the Asp-Arg salt bridges and that intermolecular salt bridge formation 
involving the same residues is not essential for the formation o f  PrP-res. The unfolding 
pathway o f  PrP-sen and its conversion to PrP-res, however, are influenced by interactions 
involving the helix 1 aspartic acid residues that appear to be independent o f  PrP-sen
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Species Helix 1 Primary Sequence Reference
Accession
Number
Hamster 144-D W E D R Y Y R E N (Oesch et al. 1985) UJHYIH
Mouse 143-D W E D R Y Y R E N (Westaway et al. 1987) P04925
Human 14 4 -D Y E D R Y Y R E N (Liao et al. 1986) NP_000302
Macaque
Monkey 14 4 -D  Y E D R Y Y R E N (Schatzl et al. 1995) S53624
Sheep 147-D Y E D R Y Y R E N (Goldmann et al. 1990) P23907
Elk 147 -D  Y E D R Y Y R E N (Raymond et al. 2000) AAF80282
Mule Deer 147-D Y E D R Y Y R E N (O'Rourke et al. 1998) AAC33174
White-tailed
Deer 147 -D Y E D R Y Y R E N
(Raymond et al. 2000) AAF80283
Cat 147-D Y E D R Y Y R E N Unpublished AAB70468
Dog 148-D Y E D R Y Y R E N Unpublished AAB99743
Cattle 155 -D Y E D R Y Y R E N (Hope et al. 1988) PI 0279
Table 4. Primary sequence alignments o f  highly conserved helix 1 residues from a 
variety o f  species. The residue number for the N-terminal sides o f  the sequences are 
given at the beginning o f  each sequence. All sequences and Genbank accession numbers 
were obtained from the PubMed protein sequence databank (National Library o f
Medicine 2003).
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binding to PrP-res. These results provide insight into the basic mechanism o f  PrP-res 
formation.
B. E x p e r im e n t a l  M e t h o d s
1. Cloning o f  w ild  type and m utant ham ster P rP  fo r  expression using E. coli— The
plasmid encoding Syrian hamster PrP (HaPrP) (residues 23-231) was generously 
provided by Dr. Marshall Bloom. It was constructed in a pET24a(+) expression vector 
from Novagen inserted as an Ndel fragment using standard cloning techniques (Russell 
2001). Mutations at positions 144, 147 and both 144 and 147 were introduced using the 
QuikChange Site-directed Mutagenesis Kit from Stratagene. The mutagenesis was 
performed by mixing the plasmid pET24a(+) DNA (-1 0  ng) containing the wild type 
hamster PrP insert in reaction buffer (10 mM KC1, 10 mM (NH^SO,*, 20 mM Tris/HCl, 
2 mM MgSC>4 , 0.1% Triton X-100, 0.1 mg/mL bovine serum albumin, pH 8 .8 ) and 
excess free deoxynucleotide triphosphates (dNTP) with oligonucleotide primers (125 ng) 
that are complementaiy to a portion o f  the hamster PrP DNA sequence except where the 
desired mutation is encoded. Samples were then thermocycled using a Perkin Elmer 
GeneAmp PCR System 9600 with PfuTurbo DNA polymerase (2.5 units) to extend and 
incorporate the mutant primers resulting in circular, double-stranded DNA using the 
following cycling parameters:
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Segment Cycles Temperature Time
1 1 95°C 30 seconds
2 1 2 95°C 30 seconds
55°C 1 min
6 8 °C 1 2  min*
* 2  min/kb o f  plasmic length; plasmid size was 5961 bp.
Oligonucleotides used in the mutagenesis were obtained from Genosys 
Biotechnologies and include the following: (D144N) 5'- 
GCATTTTGGCAATAACTGGGAGGACCGCTACTACCG-3' and 5'- 
CGGTAGTAGCGGTCCTCCCAGTTATTGCCAAAATGC-3'; (D147N) 5'- 
GCAATGACTGGGAGAACCGCTACTACCGTGAAAAC-3' and 5'- 
GTTTTCACGGTAGTAGCGGTTCTCCCAGTCATTGC-3'; (D144N/D147N) 5'- 
GCATTTTGGCAATAACTGGGAGAACCGGTACTACCG-3' and 5’- 
CGGTAGTAGCGGTTCTCCCAGTTATTGCCAAAATGC-3'. After thermocycling, the 
samples were treated with Dpn I  endonuclease (2.5 units) for 1 hour at 37°C to remove 
the methylated template DNA leaving only the newly amplified, unmethylated mutant 
circular double-stranded DNA. The circular DNA was then transformed into XL-1 Blue 
supercompetent Escherichia coli (E. coli) for mutant DNA expression. Transformations 
were performed according to the supplier’s directions. Briefly, supercompetent XL 1-Blue 
cells were thawed on ice and then 50 pL aliquots were transferred to pre-chilled Falcon 
2059 tubes. One-microliter aliquots o f  the Dpn I-treated DNA were transferred to the
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cells which were subsequently incubated for 30 min on ice with occasional swirling.
After the incubation, cells were heat shocked for 45 seconds at 42°C and then cooled on 
ice for 2 min using a Brinkmann RM 6  thermostatted water bath. To grow cells containing 
the plasmid DNA, 0.5 mL SOC broth (20 g/L bacto tryptone, 5 g/L bacto yeast extract,
10 mM NaCl, 7 mM KC1, 10 mM MgCl2, 10 mM M gS04, 20 mM glucose) was added 
and cells were incubated at 37°C with shaking at 250 RPM for 1 hour. After the 
incubation, cells were plated on Luria-Bertani (LB) agar containing antibiotic (171 mM  
NaCl, 10 g/L tryptone, 5 g/L yeast extract, 20 g/L agar, 50 mM kanamycin, pH 7.0). 
Plates were incubated -1 6  hours at 37°C to grow transformed colonies containing the 
mutant plasmid. Mutant plasmid DNA was purified from 1.5 mL overnight cultures o f  
transformed colonies in LB broth using a Promega Wizard Miniprep Plasmid Purification 
Kit. The kit procedure is based on alkaline lysis o f  bacterial cells followed by adsorption 
o f DNA onto silica in the presence o f  high salt (Vogelstein and Gillespie 1979). The 
procedure is performed as follows: Cells from the overnight culture are pelleted by 
centrifugation for 2 min at 10,000 x g. After discarding the supernatant, the cells were 
resuspended in 300 pL resuspension buffer (50 mM Tris/HCl, 10 mM EDTA, 100 pg/mL 
RNase A, pH 7.5). After resuspension, 300 pL lysis buffer (0.2 M NaOH, 1% SDS) was 
added with gentle mixing to disrupt cell membranes. Following lysis, 300 pL 
neutralization solution (1.32 M potassium acetate, pH 4.8) was added with gentle mixing 
to return the solution closer to neutral pH causing the precipitation o f  cellular 
components. Following neutralization, the lysates were centrifuged at 10,000 x g for 5 
min to remove the precipitated cellular components. The supernatant was then applied to
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silica resin column. The silica resin preferentially binds the highly negatively charged 
plasmid DNA. The DNA-bound resin was then rinsed with wash buffer (80 mM 
potassium acetate, 8.3 mM Tris/HCl [pH 7.5], 40 pM EDTA, 55% ethanol). DNA was 
eluted by adding -3 0  pL Tris-EDTA (TE) buffer (10 mM Tris/HCl, 1 mM EDTA, pH 
8.0) and spinning the column for 1 min at 10,000 x g. The plasmid DNA for all constructs 
was sequenced by MWG Biotech. For expression, plasmids containing the desired HaPrP 
construct were transformed into BL21(DE3) supercompetent cells from Stratagene for 
PrP expression. Recombinant proteins accumulated in cytoplasmic inclusion bodies and 
were purified as described below.
2. Prokaryotic Protein Expression and Purification—Cells o f  E. coli BL21(DE3) with 
the desired PrP construct were grown overnight in 5 mL o f  NZ-amine/yeast (NZY) 
medium (100 mM NaCl, 25 mM MgCb, 10 g/L NZ-amine [Sigma], 5 g/L yeast extract, 
pH 7.2) containing 0.05 mg/mL kanamycin. The overnight culture was added to 500 mL 
NZY medium with 0.05 mg/mL kanamycin and grown at 37°C in a shaking incubator to 
an optical density at 600 nm o f  0.5. Protein expression was then induced by adding 
isopropyl-P-D-thiogalactoside to 0.5 mM to the culture. The induced culture was grown 
for 2 hours at 37°C in a shaking incubator. Cells were then harvested by centrifugation.
Cell pellets were suspended in lysis buffer (50mM Tris/HCl pH 7.5, 2 mM 
EDTA, 0.1% Triton X-100) and sonicated to release the inclusion bodies containing the 
protein o f interest. Inclusion bodies were collected by centrifugation and then solubilized 
for 2 hours in 8  M urea buffered at pH 8  with 0.1 M sodium phosphate and 0.01 M Tris.
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The solubilized protein solution was then diluted 10-fold with 8.0 M urea in Tris-chloride 
buffer (TCB; 20mM Tris/HCl pH 8.0, 150 mM NaCl, 2.5 mM CaCl2). The solubilized 
protein solution was purified using His-Bind resin (Novagen). The resin was incubated 
with the solubilized protein in 8  M urea for 2 hours. The protein bound resin was loaded 
onto the column and washed with a 2 M step gradient down from 8  to 0 M urea in TCB. 
The protein was eluted using 60 mM imidazole (Fisher) in TCB followed by 200 mM 
imidazole in TCB. Fractions were analyzed using sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS/PAGE) to confirm the presence o f PrP (molecular mass 23 kDa) 
and identify fractions containing impurities. SDS/PAGE was performed using precast 
10% Nupage polyacrylamide gels (Novex). Samples containing volumes from individual 
fractions were boiled in sample buffer (SABU; 62.5mM Tris/HCl, 5% [v/v] glycerol, 3 
mM EDTA, 5% [w/v] SDS, 0.02% [w/v] bromophenol blue, 4 M urea, 4% [v/v] P- 
mercaptoethanol [PME]) for 5 min prior to loading onto gels. Gels were run in Xcell II 
gel boxes (Novex) at 200 V for 1 hour. Gels were fixed for 20 min in fixative (50% 
methanol, 1 0 % acetic acid), washed in water, and stained for 2  hours to overnight with 
GelCode Blue stain reagent (Pierce). Destaining was performed for 1 hour in water. Gels 
were documented using a Gel-doc imaging system (Bio-Rad). Fractions containing only 
PrP were pooled and dialyzed against 0.01 M sodium phosphate at pH 6.0 to remove the 
imidazole and then concentrated using a centrifugal filter device (Millipore, molecular 
weight cut-off 10 kDa) to approximately 0.5 mg/mL final protein concentration ( e 2go =  
2.7 mL/mg cm).
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3. Protein purity and disulfide bond analysis— Sample purity and the presence o f  the 
disulfide bond (between residues C l79 and C214 ofHaPrP) was determined using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS/PAGE) with precast 
14% Tris-glycine polyacrylamide gels (Novex) with SDS running buffer (0.1% [w/v]
SDS, 25 mM Tris/HCl, 200 mM). For oxidized samples, 180 ng o f  protein was added to 
oxidizing sample buffer (62.5 mM Tris/HCl, 5% [v/v] glycerol, 3 mM EDTA, 5% [w/v] 
SDS, 0.02% [w/v] bromophenol blue, 4 M urea) and boiled for 5 min prior to loading 
onto gel. Reduced samples were prepared by added 180 ng protein to reducing sample 
buffer (62.5mM Tris/HCl, 5% [v/v] glycerol, 3 mM EDTA, 5% [w/v] SDS, 0.02% [w/v] 
bromophenol blue, 4 M urea, 80 mM iodoacetamide, 4% [v/v] p-mercaptoethanol [PME]) 
and boiling for 5 min prior to loading onto gel. Electrophoresis was performed for 1.5 
hours at 125 V using an Xcell II gel box (Novex) and a PowerPac 1000 power supply 
(Bio-Rad). Following electrophoresis, gels were fixed in fixative, stained in GelCode 
Blue (Pierce), and recorded as described above.
4. M ass Spectrometry o f  Recom binant H aPrP—Molecular masses for all purified 
recombinant E. coli protein constructs were confirmed following trypsin digestion using 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry. Proteins were precipitated in methanol (3 volumes methanol: 1 volume 
buffer) to remove interfering storage buffer ions. Precipitated proteins were pelleted by 
centrifugation for 35 min at 20,800 x  g (Eppendorf Centrifuge 5417R). Supernatants were 
removed by aspiration and then the precipitated proteins (0.2-0.3 pg) were suspended in
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50 jul o f  20 pg/mL sequence grade trypsin (Promega) in 25 mM NH 4HCO3 at pH 8.0 and 
incubated overnight at 37°C. Salt contaminants were removed using ZipTipcis 
(Millipore) hydrophilic resin containing pipette tips. Prior to loading samples, tips were 
washed with 100% acetonitrile (MeCN; Sigma) and then equilibrated with 50% (v/v) 
MeCN, 0.1% (v/v) trifluoroacetic acid (TFA; Sigma) followed by just 0.1% TFA. 
Volumes (10 pL) o f  the trypsin-digested samples were acidified with 1 pL 10% TFA 
prior to loading onto the 0.1% TFA equilibrated ZipTips. Loaded samples were washed 
with 0.1% TFA and then eluted with 3 pL 50% MECN, 0.1% TFA. Eluted samples were 
diluted volumetrically by a factor o f  ten in a-Cyano-4-hydroxycinnamic Acid (CHCA) 
matrix (10 mg CHCA/mL 50% MECN, 0.1% TFA). Mass data was acquired using a 
Voyager-DE STR MALDI-TOF mass spectrometer (PerSeptive Biosystems). Spectra 
were obtained using 100 nsec extraction mode delay, positive polarity, 20,000 V  
accelerating voltage, and 50 laser shots per spectrum. Spectra were calibrated using 
known trypsin and PrP masses (842.5100, 988.4601, and 1102.5322).
5. Generation o f  M utant H aPrP GPT pSF F  Expression Vectors— D-to-N mutant 
HaPrP (residues 23-231) in the pET24a(+) vector were subcloned using Bsu36 I and Stu I 
restriction sites into a gene encoding full length HaPrP without the 
glycosylphosphatidylinositol (GPI) anchor inserted in a pBluescript vector generously 
provided by Dr. Bruce Chesebro. The pBS HaPrP construct lacked the GPI anchor 
because the gene lacked the C-terminal GPI attachment sequence (Kocisko et al. 1994). 
The cloning was performed using standard techniques (Russell 2001). For generating the
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insert containing the D  to N  helix 1 mutations, DNA from the pET24a(+) vector 
containing the mutant HaPrP gene was transformed into SCSI 10 2?. coli for expression o f  
dam methylation deficient plasmid DNA. After transformation, overnight cultures o f  
transformed SCSI 10 colonies containing the HaPrP plasmid DNA were grown and dam 
methylation deficient plasmid DNA was purified as described above. Purified dam 
methylation deficient plasmid DNA containing the desired helix 1 mutant HaPrP genes in 
the pET24a(+) vector and plasmid DNA containing the wild type HaPrP gene in a 
pBluescript vector were digested for 5 hours at 37°C with Bsu36 I (20 units; New  
England Biolabs) in 100 mM NaCl, 50 mM Tris/HCl, 10 mM MgCl2, and 1 mM 
dithiothreitol (DTT) at pH 7.6. Samples were then digested for 5 hours at 37°C in the 
presence o f  Stu I (20 units; N ew  England Biolabs) buffered with 100 mM NaCl, 50 mM 
Tris/HCl, 10 mM MgCl2, 1 mM DTT, and 100 pg/mL bovine serum albumin at pH 7.6. 
Prior to electrophoresis, the Bsu361 and Stu I digested wild type HaPrP pBluescript 
DNA was treated with shrimp alkaline phosphatase (USB) to dephosphorylate the 5’- 
phosphate from the digested ends o f  the double-stranded DNA to minimize the chance o f  
self-recombination o f  the linear DNA. The digested DNA was treated with shrimp 
alkaline phosphatase (10 units) buffered with 20 mM Tris/HCl and 10 mM MgCl2  at pH 
8.0 for 4 hours at 37°C. The enzyme was inactivated by heating at 65°C for 15 min. 
Digestion products were analyzed using gel electrophoresis with 0.8% agarose gels 
buffered with Tris-boric acid-EDTA buffer (TBE, 90 mM Tris/HCl, 90 mM boric acid, 2 
mM EDTA, pH 8 ) using a Wide Mini-sub Cell GT electrophoresis unit (Bio-Rad). A  1 
kilobase DNA ladder (Gibco) was run with all electrophoresis samples to estimate the
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molecular sizes o f  all DNA samples. DNA was visualized by staining with ethidium 
bromide for 15 min, illuminating with a transilluminator (Spectroline Model TR-302), 
and photographing (Polaroid DS 34 Direct Screen Instant Camera). DNA to be used for 
ligation reactions was separated electrophoretically in 0.8% Sea Plaque low melting point 
agarose (BioWhittaker Molecular Applications) in Tris-acetic acid-EDTA buffer (TAE, 
40 mM Tris/HCl, 18 mM acetic acid, 2 mM EDTA, pH 8 ). The SeaPlaque agarose is a 
high quality agarose that is free o f  impurities that might interfere with ligation reactions. 
Gels were stained with ethidium bromide (15 min) and visualized with a transilluminator 
(Bio-Rad). The desired bands were then cut out from the gel and saved for extraction o f  
the DNA from the agarose by electroelution. Electroelution was performed using a Model 
UEA Unidirectional Electroeluter (International Biotechnologies). Agarose gel 
containing the digested DNA fragments was electroeluted for 1 hour at 100 V in 
electroelution buffer (20 mM Tris/HCl, 0.2 mM EDTA, and 5 mM NaCl, pH 8.0) using 
8.5 M ammonium acetate dyed with bromophenol blue as a salt cushion to collect the 
eluted DNA. The DNA collects in the salt cushion where it migrates more slowly due to 
the ionic interference from the high salt concentration.
After electroeluting for 1 hour, the salt cushions for each well containing sample 
were removed and saved for phenol/chloroform precipitation. Phenol/chloroform 
precipitation was used to remove any protein impurities that may have co-electroeluted 
with the digested DNA. An equal volume o f  phenol:chloroform:isoamyl alcohol (Gibco; 
25:24:1 volume ratio) was added to the electroeluted DNA and vortexed to mix the 
aqueous and organic layers. The mixture was then centrifuged for 5 min at 14,000 x  g
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(Eppendorf Centrifuge 5417R) to separate the organic and aqueous phases. The organic 
layer, containing the bromophenol blue and protein impurities, was removed by pipette 
and the aqueous layer, containing the DNA, was ethanol precipitated to further purify the 
DNA in 95% ethanol at -20°C for 2 hours. The precipitated DNA was then pelleted by 
centrifugation at 14,000 x  g for 35 min at 4°C. After discarding the supernatant, the 
precipitated DNA was purified further by washing with 70% ethanol. The washed and 
precipitated DNA was pelleted again by centrifuging 15 min at 14,000 x  g. This last wash 
step helps to remove any residual salt impurities that may have co-precipitated with the 
DNA. After discarding the 70% ethanol wash supernatant, the DNA was resuspended in 
TE buffer (10 mM Tris/HCl, 1 mM EDTA, pH 8.0) and analyzed by agarose gel 
electrophoresis as described above to confirm the correctly sized digested insert and 
vector DNA were obtained.
The Bsu361 and Stu I digested insert DNA containing the desired HaPrP helix 1 
mutation was ligated to the Bsu361 and Stu I digested dephosphorylated vector DNA  
containing the wild type HaPrP gene using T4 DNA ligase (New England Biolabs). 
Reactions were performed by mixing insert DNA with vector DNA at a 10:1 ratio with 
T4 DNA ligase (120 units) buffered with IX T4 DNA ligase buffer (Gibco; 50 mM 
Tris/HCl, 10 mM MgCl2 , 1 mM adenine triphosphate [ATP], 1 mM DTT, 5% [w/v] 
polyethylene glycol-8000, pH 7.6). The polyethylene glycol present in the ligase buffer 
acts as a molecular concentrator by increasing the number o f  collisions between insert 
and vector DNA through partitioning o f  the hydrophilic DNA molecules from the more 
hydrophobic ethylene glycol, thus making successful ligation interactions more probable.
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Samples were incubated 10 hours at 15°C using a thermostatted water bath (Brinkman). 
Ligations were performed at low temperatures to minimize melting o f  the ends o f the 
linear DNA molecules in order to increase the ligation efficiency.
Following ligation, samples were transformed into XL1 Blue supercompetent E. 
coli using the same protocol described above. The DNA from successfully transformed 
colonies was then purified as described above and screened using Bsu361 and EcoR I 
restriction enzyme digestion. Conditions for the Bsu361 digest were the same as 
described above. DNA was digested at 37°C for 2-5 hours using EcoR I (50 units; N ew  
England Biolabs) buffered with 50 mM NaCl, 100 mM Tris/HCl, 10 mM MgCh, and 
0.025% Triton X-100 at pH 7.5. Digested DNA was separated using agarose gel 
electrophoresis as described above. DNA with the correct inserts were identified by the 
presence o f  a -7 5 0  bp band, corresponding to the HaPrP gene insert, along with a -3000  
bp band corresponding to the pBluescript vector without the HaPrP insert. The Bsu36 I 
digest was used to confirm the presence o f  only one Bsu361 cleavage site present on the 
HaPrP insert.
DNA that met the screening criteria were subsequently sequenced to confirm the 
exact DNA sequence. DNA was prepared for sequencing using a DNA Sequencing Kit 
with Big Dye Terminator Cycle Sequencing Ready Reaction (Applied Biosystems) with 
m l3 primers (Amersham Biosciences) and primers directed to wild type hamster PrP 
(generously provided by Dr. Ina Vorberg). Primer sequences are as follows: m l3  forward 
5’-GTAAAACGACGGCCAGT-3’; m l3  reverse 5’-CAGGAAACAGCTATGAC; HaPrP 
624 Forward 5’-CCCTGGAGGCAACCGTTACCC-3’; HaPrP 604 reverse 5’-
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TCGGTCTCCGTGAAGTTCTCCC. Sequencing reactions were performed by adding 1 
pg DNA to 3 pmol primer in the presence o f  the Big Dye Terminator reaction mix. The 
reaction mix consisted o f  Tris/HCl (pH 9.0), magnesium chloride, deoxynuceoside 
triphosphates, Amplitaq DNA polymerase, and A, C, G and T-Big Dye Terminator 
nucleotides, which each contained unique fluorescent probes for nucleotide distinction. 
Reactions were thermocycled using the following parameters:
Segment Cycles Temperature Time
1 1 95 °C 2 min
2 30 95°C 25 seconds
50°C 30 seconds
62°C 3.5 min
3 1 62°C 1 min
Reaction products were purified using Centri-Sep columns (Princeton Separations) which 
remove salts and low molecular compounds, including unreacted deoxynucleoside 
triphosphates less than 16 bp from amplified sequence reaction mixtures. The purified 
reaction products were then transferred to a 96 well plate (Applied Biosystems) for 
sequence detection using an Applied Biosystems 3700 automated sequencer. The 
obtained sequences were aligned using Sequencher software.
For expression in mammalian cells, the sequenced helix 1 mutant pBluescript 
clones were subcloned into the pSFF retroviral expression vector generously provided by
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Dr. Bruce Chesebro. PSFF vector and insert DNA containing the HaPrP gene with the 
helix 1 mutations were prepared by digesting the pBluescript clones with EcoR I, 
separating the digestion products, and then purifying and isolating them as described 
above. The vector DNA was also treated with shrimp alkaline phosphatase prior to the 
separation step as described above. Purified pSFF vector and insert DNA were ligated 
using T4 DNA ligase as described above using a 5:1 insert to vector molar ratio. Ligated 
DNA was transformed into JM109 supercompetent E. coli (Stratagene) which is a 
recombination deficient strain that minimize the chance o f  recombination events that 
large plasmids, such as pSFF, are more likely to undergo. Transformed plasmid pSFF 
DNA was screened for the correct orientation o f  the PrP insert using EcoR I and Bsu36 I 
restriction enzyme digestion as described above. The pSFF vector containing the mutant 
HaPrP gene insert has two Bsu36 I restriction sites: one with the pSFF vector and one in 
the HaPrP gene insert. As a result, vector DNA containing the HaPrP gene digested into 
two segments which varied in size based on the orientation o f  the FlaPrP gene insert. 
Bsu36 I digests o f  plasmid DNA containing the correctly oriented insert produced 1968 
and 7519 bp bands when analyzed by agarose gel electrophoresis, while the digests o f  
plasmid DNA containing incorrectly oriented insert produced 2313 and 7174 bp bands. 
Samples were separated by agarose gel electrophoresis, stained with ethidium bromide 
and visualized as described above.
The D-to-A HaPrP mutants were generated by site directed mutagenesis o f  the 
same wild type full length HaPrP pBluescript clone provided by Dr. Chesebro using a 
QuikChange Site-directed Mutagenesis Kit from Stratagene as described above.
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Oligonucleotides were obtained from Genosys Biotechnologies and include the 
following: (D144A) 5 ’-GCATTTTGGCAATGCCTGGGAGGACCGCTACTACCG-3 ’ 
and 5 ’-CGGTAGTAGCGGTCCTCCC AGGCATTGCCAAAATGC-3’; (D147A) 5’- 
GCAATGACTGGGAGGCCCGCTACTACCGTGAAAAC-3’ and 5 ’- 
GTTTTCACGGTAGTAGCGGGCCTCCCAGTCATTGC-3’; (D144A/D147A) 5’- 
GCATTTTGGCAATGCCTGGGAGGCCCGCTACTACCG-3’ and 5 ’- 
CGGTAGTAGCGGGCCTCCCAGGCATTGCCAAAATGC-3’. After mutagenesis and 
plasmid DNA purification using a Qiagen Qiaprep Spin Miniprep Kit (which follows the 
same basic protocol as the Promega Wizard Miniprep Kit described above), the pBS PrP 
clones were then sequenced with an Applied Biosystems 3700 automated sequencer and 
subcloned using standard techniques as described above into the pSFF retroviral 
expression vector using the EcoR I restriction site (Chesebro et al. 1993). All constructs 
were screened for orientation using Bsu36 I and EcoR I restriction enzymes as described 
above.
6. Generation o f  H aPrP expressing eukaryotic cells—Plasmid pSFF DNA containing 
the correctly oriented wild type and mutant HaPrP gene inserts were transfected into 
mixtures o f  PA317 and \|/2 mouse fibroblast cells (generously provided by Dr. Bruce 
Chesebro) using an Effectene Transfection Kit (Qiagen). In a single well o f a 6 well plate 
(Coming), 1.25 x  105 \|/2 mouse fibroblast cells and 1.5 x 105 PA317 and mouse 
fibroblast cells (generously provided by Dr. Bruce Chesebro), suspended in RPMI 
medium (ICN Biomedicals) supplemented with 10% (v/v) fetal bovine serum (Hyclone),
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2 mM L-glutamine (Gibco), 1 unit/mL penicillin (Gibco), and 1 pg/mL streptomycin 
(Gibco), were plated and incubated overnight at 37°C. The next day, transfections were 
performed on the plated cells. The transfections were performed by adding 1 pg pSFF 
plasmid DNA containing the desired HaPrP construct to the transfection reagents. The 
transfection kit reagents form micellar complexes with the added DNA, which are 
permeable to cell membranes. After the DNA complexes are taken up by cells, the DNA  
is incorporated into the chromosomal DNA o f  the host cell via retroviral mechanisms. 
The incorporated retroviral gene then proceeds to express, among other proteins, the 
retroviral virus capsid structural protein, Gag, and the inserted HaPrP mutant protein 
(Chesebro et al. 1993). Transfected cells were cultured and subsequently screened for 
protein expression by immunoperoxidase staining and used for metabolically labeled 
protein expression as described below based on methods described by others (Kocisko et 
al. 1994; Priola et al. 1994; Robertson et al. 1992).
Transfected cells were monitored for incorporation o f  the pSFF DNA by PrP and 
Gag  immunoperoxidase staining. Immunoperoxidase staining was performed by 
suspending cells in 200 pL trypsin-EDTA (Gibco) and transferring them to a round 
bottom 96 well plate (Coming) with 50 pL fetal bovine serum (Hyclone). The plates 
containing the cells were centrifuged (Beckman GS-6R) 2 min at 1200 RPM to pellet the 
cells. Supernatants were discarded and 1 pL o f  cells were added to a 60 mm microscope 
slide (Fisher) and dried. Dried cells were fixed for 20 min in 3.7% formaldehyde in 
phosphate buffered saline (PBS; 20 mM sodium phosphate, 130 mM NaCl, pH 7.4). 
Fixed cells were blocked for 5 min using 0.1 M glycine buffered with PBS. Cells were
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then permeablized for 5 min with 0.4% (v/v) Triton X-100 buffered with PBS. After 
permeablization, cells were washed once with PBS before adding the primary antibodies. 
For detection o f  HaPrP, supernatants o f  hybridoma cells expressing the HaPrP 3F4 
antibody (generously provided by Dr. Bruce Chesebro) were incubated with the fixed, 
blocked, and permeablized cells for 30 min. For detection o f  the retroviral capsid protein, 
Gag, supernatants o f  hybridoma cells expressing the Gag antibody 18-8 (generously 
provided by Dr. Bruce Chesebro) were incubated with the fixed, blocked, and 
permeablized cells for 30 min. To remove the primary antibodies, cells were washed once 
for 5 min with PBS. The secondary antibody, goat anti-mouse IgG horseradish 
peroxidase (generously provided by Dr. Bruce Chesebro) was added to the 18-8 and 3F4 
antibody bound cells and incubated for 30 min. Cells were washed for 5 min in PBS to 
remove the secondary antibody prior to substrate addition. Cells were incubated for 30 
min in 3-amino-9-ethyl-carbazole (AEC) substrate (0.2 mg/mL AEC, 50 mM sodium 
acetate, 0.015% H2 O2), which reacts with horseradish peroxidase forming a water 
insoluble red precipitate. Unreacted substrate was removed by washing three times for 5 
min in PBS. Stained cells were air dried and mounted for microscopic analysis by adding 
a few drops o f  mounting solution (50% [v/v] glycerol, 2% [v/v] formaldehyde in PBS) to 
the stained cells and covering with a cover slip. Stained cells were viewed and 
photographed using an Olympus BH-2 light microscope with an Olympus OM System 
SC35 type 12 camera.
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7. M etabolic f 5SJ-methionine Labeling o f  PrP-sen—Metabolic labeling o f  PA317 and 
\|/2 mouse fibroblast cells with the wild type or mutant PrP expressing pSFF clones was 
performed using previously described methods (Caughey et al. 1999; Horiuchi and 
Caughey 1999; Kocisko et al. 1995). Cells were grown to 85-95% confluence in a 75 cm2 
flask (Coming) in RPMI medium (ICN Biomedicals) supplemented with 10% (v/v) fetal 
bovine serum (Hyclone), 2 mM L-glutamine (Gibco), 1 unit/mL penicillin (Gibco), and 1 
pg/mL streptomycin (Gibco). The growth medium was removed and cells were washed 
twice with 5 mL warm phosphate buffered balanced salts solution (PBBS; 1.5 mM 
KH2P 04, 8.1 mM Na2P 0 4, 1.3 mM CaCl2, 4.3 mM KC1, 123 mM NaCl, 1 mM MgCl2,
0.8 mM MgSCL, 1% [w/v] phenol red, 5.6 mM glucose, pH 7.3). Cells were starved o f  L- 
methionine by adding warmed labeling medium (3.5 mL; methionine depleted RPMI 
medium [ICN Biomedicals] supplemented with 1.5 mg/L L-methionine, 15 mg/L L- 
glutamine, and 5% [v/v] dialyzed FBS [Hyclone]) to the PBBS-washed cells. Flasks were 
treated with air containing 5% C 0 2 and incubated in a model 4200 C 0 2 incubator 
(Napco), receiving 0.4 L/min C 0 2 and 4 L/min air, for 30 min at 37°C. Following the 
starvation incubation, 3 mCi o f  [35S]-methionine (NEN) was added to the labeling 
medium and cells were incubated for 2.5 hours at 37°C. Following the labeling 
incubation period, flasks were removed from the incubator and iced for 2 min to drain the 
labeling medium from the cell surface. The labeling medium was removed and cells were 
washed three times with 5 mL ice cold PBBS. Cells were lysed by adding 3 mL lysing 
buffer (0.5% [v/v] Triton X-100, 0.5% sodium deoxycholate, 5 mM Tris/HCl [pH 7.4 at 
4°C], 150 mM NaCl, 5 mM EDTA) and incubating 2 min to allow cell lysis (Caughey
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and Raymond 1991; Caughey et a l  1995). Cell lysates were then centrifuged for 5 min at 
1000 x g using a J6B centrifuge (Beckman) to remove cellular debris. Supernatants were 
removed and methanol precipitated by adding 12 mL methanol and incubating at -20°C 
for two hours. Precipitated proteins were centrifuged for 20 min at 5,000 x  g and the 
supernatant was discarded. Pelleted proteins were washed once with 3 mL TN-sark buffer 
(50 mM Tris/HCl [pH 7.0 at 4°C], 0.5 M NaCl, 1% [w/v] sarkosyl) and then resuspended 
in 1 mL detergent, lipid, protein complex (DLPC; 4.2 mg/mL L-a-phosphatidylcholine 
[Sigma], 50 mM Tris/HCl [pH 7.5 at 25°C], 2% sarkosyl, 120 mM NaCl) supplemented 
with protease inhibitors (0.1 mM pefabloc [Boerhinger-Mannheim], 0.15 nM aprotinin 
[Boerhinger-Mannheim], 1 nM leupeptin [Boerhinger-Mannheim], 1 nM pepstatin 
[Boerhinger-Mannheim], 0.5 mM EDTA) by sonication for 2 min at full power using a 
cuphom sonicator (Heat Systems Ultrasonics). After resuspending the proteins, 3.5 pL 
3F4 monoclonal antibody (generously provided by Greg Raymond) directed towards 
HaPrP was added to the resuspended protein-DLPC solutions to immunoprecipitate the 
[35S]-labeled HaPrP proteins (Caughey et al. 1995). Solutions were incubated overnight 
at 4°C to allow antibody binding. Antibody-bound protein was removed from solution by 
adding 50 pL o f a 50% (resin volume/total volume) CL-4B protein-A sepharose (PAS; 
Pharmacia) equilibrated in lysing buffer and incubating with rotation on a LabQuake 
rotisserie shaker (Bamstead-Thermolyne) for 1 to 2 hours at 4°C. Radiolabel led HaPrP 
bound PAS beads were centrifuged for 1 min at 20,000 x g and the supernatant was 
discarded. The pelleted PAS was washed once with 0.5 mL DLPC, twice with 1 mL TN- 
sark, and once with 1 mL distilled-deionized water. Following each wash, all liquid was
95
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
aspirated. [35S]-labeled HaPrP protein was eluted by adding 45 pL 0.1M acetic acid (pH 
~2.75) and incubating at 25°C for 35 min. Eluted [35S]-labeled HaPrP was quantitated by 
scintillation counting 1 pL eluate in 5 mL Ready-Safe scintillation cocktail (Beckman) 
using a LS6500 Multi-purpose scintillation counter (Beckman). Radiolabel led eluates 
were stored at 4°C until use.
8. Circular Dichroism Spectroscopy and Denaturation Curves—Circular Dichroism 
spectroscopy was performed using an OLIS CD module with Cary-16 Spectrophotometer 
Conversion Unit with a NESLAB RTE-111 temperature control module. For thermal 
denaturation experiments the ellipticity from 225 to 207.5 nm o f PrP samples at 0.3 
mg/mL in 0.01 M sodium phosphate at pH 6.0 was measured at intervals between 25 and 
72.5°C. Full spectra at 25, 62.5 and 72.5°C were scanned from 185 to 260 nm. Samples 
were scanned 3 times with a 0.5 nm scanning interval in a 1.0 mm cylindrical cell after 
equilibrating 15 min at the desired temperature. Scans were averaged using the OLIS 
spectral processing software supplied with the instrument. The fraction o f  unfolded 
protein for each construct was determined using the molar ellipticity at 222 nm and was 
plotted versus the temperature in degrees Celsius. The ellipticity at 72.5°C was used for 
the unfolded protein ellipticity. The ellipticity was converted to molar ellipticity, 0, using 
the following equation:
Q M O ’
c l
Equation 7
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Where 0Obs is the observed ellipticity, c is the protein concentration in moles per liter and 
I is the cell path length in cm (Johnson 1990). All o f  the mutant protein signals were 
normalized to the wild type PrP unfolded signal. Averages and standard deviations o f  
transition midpoints values and slopes were determined from three individual 
experiments for each protein.
For the GdnHCl denaturation, samples from 0 to 5.0 M GdnHCl were prepared by 
diluting a stock PrP solution (0.3 mg/mL) with varying amounts o f  a stock 8.0 M 
GdnHCl solution and buffer giving a final protein concentration o f 0.1 mg/mL. All 
solutions were buffered at pH 6.0 in 0.01 M N aP 04. Samples were allowed to equilibrate 
for at least one hour prior to analysis. Samples were scanned 3 times in a 1.0 mm 
cylindrical cell from 225 to 207.5 nm with a 0.5 nm scanning interval at 25°C. All 
spectral data were corrected for absorbance by the buffer and denaturant. The fraction o f  
unfolded protein was determined for each construct using the ellipticity at 222 nm. 
Averages and ranges for the thermodynamic parameters were determined from two 
individual experiments for each protein. Thermal and GdnHCl denaturation curves were 
fit using the nonlinear regression analysis tool on GraphPad Prism. Thermal unfolding 
transition midpoints and GdnHCl denaturation thermodynamic parameters were 
determined assuming a two-state unfolding process as described by Pace and Scholtz 
(Pace 1986; Pace and Scholtz 1996). Plots o f  AG versus GdnHCl concentration were fit 
by linear regression according to Equation 6 as described above.
9. Preparation o f  Purified PrP-res—Purified PrP-res from 263K scrapie infected
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hamsters was generously provided by Greg Raymond. It was prepared using a revision 
of the Bolton et al. method (Bolton et a l  1987). Brains were harvested from hamsters 
inoculated with 263K scrapie showing middle to late-stage clinical symptoms. Animals 
were sacrificed by asphyxiation with CO2  for 4 min. Brains were excised, rinsed in PBS 
to remove residual blood, dried by gently blotting onto filter paper (Whatman), flash 
frozen by placing into liquid nitrogen, and stored at -80°C. To prepare PrP-res, frozen 
brains were thawed, weighed, and rinsed 6 times with -1 0 0  mL ice cold PBS. Brains 
were suspended to give a 10% (w/v) suspension in buffer 1 (10% [w/v] sarkosyl, 10 mM 
Tris/HCl [pH 8.3 at 4°C], 1 mM EDTA, 133 mM NaCl, ImM DTT, 0.5 mM pefabloc,
0.15 nM aprotinin, 1 nM leupeptin, 1 nM pepstatin). The suspension was homogenized 
using a dounce homogenizer (6 strokes with loose pestle, 10 strokes with tight pestle) and 
incubated at 25°C for 1 hour with occasional stirring. Homogenates were transferred to 
Optiseal tubes (Beckman) and ultracentrifuged at 22,000 x g for 30 min using a TL 100.3 
Ultracentrifuge (Beckman) with a type 50.2 rotor (Beckman). Supernatants were 
transferred to a new Optiseal tube and ultracentrifuged again at 150,000 x  g for 3 hours at 
4°C. Supernatants were discarded and the pellets were rinsed with 5 mL buffer 2 (10% 
[w/v] NaCl, 1% [w/v] zwittergent 3-14 [Calbiochem], 10 mM Tris/HCl [pH 8.3 at 4°C],
1 mM EDTA, ImM DTT) and then resuspended by douncing in buffer 2 (1-2 mL buffer
2 per g starting brain material) at 25°C. Resuspended pellets were transferred to Optiseal 
tubes and ultracentrifuged at 225,000 x g for 2 hours at 20°C. Supernatants were 
discarded and pellets were washed with 5 mL buffer 3 (10 mM Tris/HCl, 100 mM NaCl,
5 mM MgCb, pH 7.4). Washed pellets were removed and resuspended by douncing in
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buffer 3 (0.25-0.5 mL per g starting brain material) with added protease inhibitors (0.5 
mM pefabloc, 0.15 nM aprotinin, 1 nM leupeptin, 1 nM pepstatin, 1 mM EDTA). RNA  
was removed by treating the suspensions with RNase A  (100 pg/mL; N ew  England 
Biolabs) for 2 hours at 37°C. RNase treated suspensions were supplemented with CaCb 
and treated with DNase I (20 pg/mL) for 2 hours at 37°C. After the digests, EDTA and 
NaCl were added to final concentrations o f  20 mM and 10% [w/v] respectively. After 
mixing the digests thoroughly, zwittergent 3-14 (Calbiochem) was added to a final 
concentration o f  1%. The total volume was adjusted with buffer 3 to a ratio o f  0.73 mL 
solution to 1 g staring brain material. The suspension was transferred to an Optiseal tube 
and a pad, consisting o f  1 M sucrose, 0.1 M NaCl, 10 mM Tris/HCl (pH 7.4 at 25°C), and 
1% (w/v) zwittergent 3-14, was added underneath the solution. The suspension was 
ultracentrifuged at 225,000 x g for 2 hours at 20°C. The pellet was rinsed twice and then 
dounced into 1 mL o f  a solution containing 0.5% (w/v) zwittergent 3-14 in phosphate 
buffered saline (20 mM sodium phosphate, 130 mM NaCl). The dounced suspension was 
ultracentrifuged at 350,000 x g for 30 min at 20°C. After discarding the supernatant, the 
pellet was resuspended by sonication in a cuphom sonicator in 1 mL phosphate buffered 
saline with 0.5% (w/v) zwittergent 3-14 and stored at 4°C.
Preparations were analyzed for total protein content spectrophotometrically using 
the BCA assay (Pierce) with a DU-7 spectrophotometer (Beckman). Purity was analyzed 
by silver stain SDS/PAGE and PrP amount was determined by Western blotting. 
SDS/PAGE was performed as described above using 10% NuPAGE Bis-Tris gels 
(Novex). Silver staining was performed by fixing the gels for 30 min in fixative solution
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(50% [v/v] methanol, 10% [v/v] acetic acid, 37% [v/v] formaldehyde). Fixed gels were 
then washed twice for 10 min in 50% [v/v] ethanol. Gels were pretreated with sodium 
thiosulfate (0.2 mg/mL) and rinsed three times for 20 seconds with water. Gels were then 
impregnated in a solution o f 0.2 mg/mL silver nitrate in 37% (v/v) formaldehyde for 20 
min. Gels were then rinsed twice for 20 seconds in water and developed for ~5 min in 
developer (60 mg/mL Na2CC>3 , 37% formaldehyde, 4 pg/mL Na2 S2 C>3). Gels were 
washed twice for 1 min in water and developing was stopped by adding to fixative 
solution containing 50% methanol and 10% acetic acid. Western blotting was performed 
by transferring gels onto PVDF membranes (Millipore) using a semi-dry Fastblot B34 
blotting apparatus (Biometra) at 151 mAmps for 20 min. Blotted membranes were 
blocked for 45 min with 5% (w/v) Blotto (Bio-Rad) in Tris-buffered saline-tween 
solution (TBST; 20 mM Tris/HCl, 150 mM NaCl, 0.05% [v/v] tween-20R [Sigma]). 
Blocked membranes were then incubated with a 1:10,000 dilution o f  the primary 
antibody (3F4) in 5% Blotto/TBST for 45 min. Membranes were then washed 3 times for 
5 min with TBST and then a 1:10,000 dilution o f  the secondary antibody, goat anti­
mouse IgG alkaline phosphatase, in 5% Blotto/TBST was added and incubated for 45 
min. Membranes were then washed 5 times for 5 min prior to development. Development 
was performed using Attophos chemiluminescent alkaline phosphatase substrate 
(Promega). Membranes were exposed to 1.25 mL Attophos substrate for 5 min and then 
dried overnight. Developed membranes were scanned using a STORM system 
phosphoimager (Molecular Dynamics) at 450 nm. Scanned images were analyzed using 
ImageQuant software (Molecular Dynamics).
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10. Preparation o f  N orm al Brain and Scrapie Brain M icrosomes—Crude normal and 
263K infected hamster brain microsomes were generously provided by Dr. Gerald Baron 
and were prepared as described previously (Baron et al. 2002). For a preparation, one 
Syrian golden hamster brain, either a normal brain or a brain excised from a hamster 
showing clinical signs o f  scrapie, was minced using a razor blade and homogenized by 
douncing (12 slow strokes with loose pestle, 20 strokes with tight pestle) in enough 
phosphate buffered saline supplemented with 0.5 mM pefabloc, 0.15 nM aprotinin, 1 nM 
leupeptin, 1 nM pepstatin, 1 mM EDTA, and 1 mM DTT to make a 10% (w/v) brain 
homogenate. The homogenate was sonicated using a cuphom sonicator for 3 min at full 
power. Homogenates were then centrifuged at 3000 x  g (Beckman J6-B) for 10 min and 
the supernatant was removed and saved. The pellet was resuspended in the initial volume 
o f PBS and the suspension was dounce homogenized again (20-30 strokes with the tight 
pestle). Suspensions were then pelleted again at 3000 x g and the supernatant was 
combined with the supernatant from the first spin. The pooled supernatants were 
transferred to an Optiseal tube and then ultracentrifuged in a TL100.3 ultracentrifuge 
(Beckman) with a Type 50.2 rotor at 100,000 x g for 1 hour at 4°C. The supernatant was 
discarded and the pellet was triturated using a 3 cc syringe with a -7 0 0  pL o f  PBS. After 
transfer to a 15 mL tube (Coming), triturated pellets were suspended by sonicating for 7 
min using a cuphom sonicator at full power and by pipetting up and down using a PI 000 
pipettor (Rainin). Samples were stored at -20°C until use. Total protein and PrP
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quantification was performed by BCA assay and by Western blot as described for the 
purified PrP-res preparations.
11. Cell-Free Conversion Reactions—Cell-free conversion reactions were performed 
following the basic procedures described previously with modifications (Baron et al. 
2002; Caughey et al. 1995; Horiuchi and Caughey 1999; Kocisko etal .  1994). Two 
different types o f  cell-free conversion reaction conditions were used: 1) reactions using 
purified PrP-res and 2) reactions using PrP-res in brain microsomes. All reactions were 
performed at pH 6.0 and contained 100 ng o f  263K PrP-res mixed with 10,000 to 20,000 
cpm [35S]PrP-sen in the presence o f  the standard conversion reaction components: 50 
mM sodium citrate, 12 mM NaCl, 2 mM sodium phosphate, and 18 mM acetic acid. 
Among the two conversion reaction types, there were a total o f  six different conversion 
reaction sub-types that varied by the containment o f  additional conversion reaction buffer 
components and presence o f  PrP-res pretreatments.
For reactions using purified PrP-res, five different conversion reaction subtypes 
were used: guanidine pretreated PrP-res, guanidine-free, denaturant-free, urea pretreated 
PrP-res, and denaturant/detergent free. Cell-free conversion reactions using guanidine 
pretreated purified PrP-res were performed by pretreating the PrP-res in 4.0 M GdnHCl 
for 1 hour at 37°C prior to adding the [35S]PrP-sen. Pretreated PrP-res was then added to 
[35S]PrP-sen and additional buffer components resulting in a solution containing, in 
addition to the standard reaction components listed above, 364 mM GdnHCl, 5 mM cetyl 
pyridinium chloride, 34 mM sarkosyl, and 1.25 mM zwittergent 3-14. For guanidine-free
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conversion reactions, there was no pretreatment o f  PrP-res. Instead, purified PrP-res was 
mixed with [35S]PrP-sen and additional components resulting in a final conversion buffer 
containing the standard conversion reaction components, 21 mM sarkosyl, 1.25 mM 
zwittergent 3-14,100 mM NaCl, and 5 mM MgCl2. Denaturant-free conversion reactions 
were performed by adding purified PrP-res without pretreatment to [35S]PrP-sen in the 
presence o f  the standard conversion reaction components, 1.25 mM zwittergent 3-14, 100 
mM NaCl, and 5 mM MgCl2. For urea pretreatment conversion reactions, purified PrP- 
res was pretreated in 6.0 M urea for 1 hour at 37°C prior to preparing the conversion 
reaction mixture. Urea pretreated PrP-res was added to [35S]PrP-sen and additional buffer 
components resulting in a solution containing the standard conversion reaction 
components, 545 M urea, and 1.25 mM zwittergent 3-14. Denaturant/detergent-free 
conversion reactions were performed by, prior to setting up the conversion reaction, 
removing the zwittergent 3-14 detergent from the purified PrP-res storage buffer by 
pelleting the PrP-res for 30 min at 20,800 x g, removing the supernatant by aspiration, 
washing with PBS, and repeating two more times. The detergent free, purified PrP-res 
was then mixed with [35S]PrP-sen and additional components resulting in solutions 
containing the standard conversion reaction components, 100 mM NaCl and 5 mM 
MgCl2.
For conversion reactions using PrP-res in brain microsomes, two conversion 
reaction sub-types were performed: reactions with and without the detergent sarkosyl. For 
conversions using microsomal PrP-res without sarkosyl, final reaction mixtures contained 
the standard conversion reaction components in addition to 100 mM NaCl and 5 mM
103
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
MgCl2 . For conversions using microsomal PrP-res with sarkosyl, final reaction mixtures 
contained 100 mM NaCl, 5 mM MgCl2 , 20 mM sarkosyl, and the standard reaction 
components. A ll conversion reactions were incubated for 40-48 hours at 37°C. After 
incubation, 90% o f  the reaction mixture was treated with 20 pg/mL o f  proteinase K (PK; 
Calbiochem) at 37°C for 1 hour. The remaining 10% was analyzed without PK treatment. 
The PK digestion was stopped by adding Pefabloc (Boehringer Mannheim) to 2 mM, 20 
pg thyroglobulin (Fluka) as a carrier protein, and four volumes o f  methanol. Precipitated 
proteins were collected by centrifugation, suspended by boiling for 5 min in sample 
buffer, and separated by SDS/PAGE using NuPAGE pre-cast, 10% Bis-Tris gels (Novex) 
as described above. Gels were fixed for 30 min in fixative (50% methanol, 10% acetic 
acid) and hydrated for 30 min in gel drying solution (4.0% glycerol, 10% ethanol) prior 
to drying for 1 hour at 60°C using a Speed Gel SG210D gel dryer (Savant). Radioactive 
proteins on dried gels were exposed to Storage Phophor Screens (Molecular Dynamics), 
visualized, and quantified using a STORM Phosphorimager and ImageQuant software 
(Molecular Dynamics).
12. Analysis o f  PrP-sen binding to PrP-res—Two types o f  PrP-res binding experiments 
based on experiments performed by Horiuchi et al. (Horiuchi and Caughey 1999) were 
performed: binding to purified PrP-res in the presence o f  anionic detergents and binding 
to microsomal PrP-res without detergents and denaturants. For binding to purified PrP-res 
in the presence o f  anionic detergents, purified 10,000-20,000 cpm [35S]-labeled PrP-sen 
and 100 ng purified 263K PrP-res were mixed yielding a total volume o f  22 pi in
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conversion reaction buffer containing detergent (0.05% [w/v] zwittergent 3-14, 1.25% 
[w/v] sarkosyl, 1.8 mM sodium phosphate, 14 mM acetic acid, 112 mM NaCl, 5 mM 
MgCb, 50 mM sodium citrate at pH 6.0). For detergent-free microsome binding 
reactions, 10,000-20,000 cpm purified [35S]-labeled PrP-sen and microsomes containing 
100 ng 263K PrP-res were mixed in 22 pi o f  the microsome conversion reaction buffer 
(1.8 mM sodium phosphate, 14 mM acetic acid, 112 mM NaCl, 5 mM MgCk, 50 mM 
sodium citrate at pH 6.0). A ll samples were mixed thoroughly and incubated for 3 days at 
37°C. After incubation, reaction mixtures were centrifuged at 20,800 x g for 20 min. The 
supernatant was saved and the resulting pellet was washed once with 180 pi o f  the same 
conversion reaction buffer without the microsomes and centrifuged again. The final pellet 
was suspended in 1% SDS. The radioactivities in the supernatant and pellet were 
quantified by scintillation counting, and [35S]PrP in both fractions was analyzed by 
SDS/PAGE and Phosphorimager analysis. In addition to the centrifuge fractions, the 
radioactivities o f tube bound PrP and PrP lost during the wash step were also determined 
by scintillation counting. Tube bound [35S]PrP was solublized by adding 1% SDS to the 
tubes that contained the reaction mixtures. The percentages o f  [35S]PrP-sen were 
determined by dividing the component radioactivity by the sum o f  the radioactivitites for 
the supernatant, pellet and tube bound [35S]PrP-sen.
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C . R e s u l t s  a n d  D i s c u s s i o n
1. Expression o f  Recom binant H aPrP Using E. coli—To investigate the roles o f  the 
helix 1 Asp residues and their proposed salt bridges on the stability o f  the secondary 
structure o f  PrP, three mutant proteins (D144N, D147N, and D144N/D147N) o f  full 
length hamster PrP (residues 23-231) were generated by site-directed mutagenesis o f  a 
clone provided by Dr. M. Bloom consisting o f  a full length wild type hamster PrP gene 
(residues 23-231) inserted into at the Nde I restriction site o f  the pET24a(+) expression 
vector. Sequencing o f  the mutagenized clones indicated that the all three mutations were 
incorporated successfully into the HaPrP gene (data not shown).
Wild type and mutant HaPrP proteins were expressed as cytoplasmic inclusion 
bodies in E. coli, and then purified and refolded for analysis by circular dichroism 
spectroscopy. The protein yields varied between the constructs. The highest yield was 
obtained for the wild type protein, which typically gave 5 mg protein per liter culture. 
The D144N and D147N mutants gave approximately 1.5 mg protein per liter culture, 
while the typical D144N/D147N mutant protein yield was the lowest at 1.0 mg protein 
per liter culture. The reasons for the variations remain to be determined. However, the 
variation does not appear to result from differences in protein expression after induction 
as SDS/PAGE analysis o f  induced and uninduced cultures indicated that the wild type 
and mutant E. coli expressed roughly the same amounts o f  protein (data not shown). The 
differences may have been because the proteins have different propensities to form 
inclusion bodies, may have different stabilities that affect protein refolding, or may have
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different affinities for binding to the nickel affinity column during purification. 
Regardless, the purification and refolding protocols yielded enough protein to perform 
the CD analysis.
The purified proteins were analyzed by SDS/PAGE to assess protein purity and 
the presence o f  the disulfide bond between C ysl79 and Cys214 (Figure 19). The slower 
migration o f  the proteins on SDS/PAGE upon treatment with P-mercaptoethanol (lanes 1- 
4) than untreated samples (lanes 5-8) indicated that the disulfide bond was present in the 
untreated preparations o f  each construct (Rezaei et al. 2002). Each protein ran as a single 
band with an estimated purity o f  at least 90%.
The purified proteins were analyzed by MALDI-TOF mass spectrometry as an 
indirect confirmation o f  the presence o f  the correct mutations. The D144N and D147N  
HaPrP proteins are theoretically 0.98 amu lower in molecular mass than wild type HaPrP 
(theoretical molecular mass 22974.65 Da), while D144N/D147N HaPrP is theoretically 
1.96 amu lower. In order to obtain the accuracy necessary for resolving 1 amu differences 
in molecular mass, since the error in measurement was 0.05% o f  the total molecular 
mass, it was necessary to proteolytically digest the wild type and mutant HaPrP proteins 
using Trypsin to generate smaller fragments o f  PrP. The mass spectra (Figure 20) show  
numerous peaks due to the proteolytic digestion o f HaPrP into multiple fragments. 
Analysis o f  the molecular masses o f  the peaks identified the peak in the wild type 
spectrum (Figure 20a) at 1534.57 amu as resulting from a PrP fragment containing both 
D144 and D147 (theoretical molecular mass for the fragment is 1534.6207). The spectra
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Reduced Oxidized
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Figure 19. Disulfide bonds are present in recombinant PrP purified and 
refolded from inclusion bodies expressed in E. coli. SDS/PAGE o f  wild type 
and helix 1 mutant hamster PrP residues 23-231 in the presence (reduced, lanes 
1-4) and absence (oxidized, lanes 5-8) o f  p-mercaptoethanol. Gels were stained 
using coomassie blue. Molecular mass markers (kDa) are indicated on the left.
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for the D144N, D147N, and D144N/D147N mutant protein Trypsin digests (Figure 20b- 
d) contained peaks from fragments that were 0.95, 0.82 and 1.89 atomic mass units lower 
respectively than the wild type protein, consistent with the respective theoretical 
molecular masses, suggesting that the proteins contained the correct mutations.
2. Thermal Denaturation o f  w ild type and m utant H aPrP—The secondary 
structures and stabilities o f  the PrP mutants relative to wild type PrP were assessed by 
CD spectroscopy. Under nondenaturing conditions at 25°C and pH 6.0 (the optimal pH 
for most PrP-res-induced cell-free conversion reactions), spectra o f  the wild type and 
mutant PrP constructs were identical (Figure 21a), each showing negative lobes at 208 
and 222 nm indicative o f  highly a-helical secondary structures as has been seen 
previously for PrP-sen derived from brain (Pan et al. 1993), mammalian tissue culture 
cells (Xiong et al. 2001) and recombinant PrP synthesized and refolded from inclusion 
bodies (Homemann et al. 1997). These data suggest the Asp residues and their respective 
salt bridges do not substantially stabilize helix 1. Thermal denaturation was performed to 
determine i f  the mutants were destabilized with respect to secondary structure and 
unfolding transitions. The thermal denaturation curves were sigmoidal for all constructs 
suggesting that they undergo a two-state unfolding transition (Figure 22). However, none 
o f  the thermal unfolding reactions for the PrP constructs were reversible so, 
thermodynamic values could not be obtained. Transition midpoints and slopes o f  the 
unfolding transition regions were used for comparison instead. The transition midpoints 
(Table 5) for the mutants were within 2.2°C o f  the wild type protein transition midpoint
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suggesting that the PrP secondary structure is not substantially destabilized by the 
mutations and the presumed elimination o f  the helix 1 salt bridges. However, the slopes 
o f the transition regions o f  the mutant unfolding curves (Table 5) were lower than the 
slope o f the wild type protein-unfolding curve. These data indicate that the mutants 
unfold differently and less cooperatively than the wild type protein.
To look more closely at the thermal denaturation differences between the wild 
type and mutant PrP molecules, CD spectra at 62.5°C, 72.5°C, and, 25°C after cooling 
from 72.5°C, were overlaid (Figures 21b-d). The wild type protein changed from a highly 
a-helical conformation at 25°C (Figure 21a) to a highly (3-sheet conformation at 62.5 and 
72.5°C as indicated by the negative peak centered at 215 nm (Figures 21b and c). At 
62.5°C all three mutants appeared to still have some a-helical content judging by the 
slight negative dips in ellipticity at 208 and 222 nm (Figure 21b). At 72.5°C the mutant 
spectra all had negative lobes around 204 nm different from the wild type spectrum, most 
noticeable in the D144N and D144N/D147N mutant spectra (Figure 21c). This difference 
indicated that the mutant proteins have different states o f  denaturation at 72.5°C than the 
wild type. Negative ellipticities below 200 nm are associated with disordered structure; 
thus, the mutant PrP conformations appeared to contain more disordered structure than 
the more [1-sheet containing wild type protein. In addition to the conformational 
differences at 72.5°C, there were differences in the reversibilities o f  the unfolding 
induced by this temperature. Thermal denaturation o f  the wild type protein was highly 
irreversible, which has been shown previously (Jackson et al. 1999), as can be seen by 
the fact that the spectra at 72.5 and 25°C after cooling from 72.5°C are shaped similarly
114
R ep ro d u ced  with p erm issio n  o f  th e  copyrigh t ow n er. Further reproduction  prohibited w ithout p erm ission .
with main negative lobes for both spectra centered close to 215 nm (Figures 21c and d). 
Spectra o f the mutant PrP molecules after cooling from 72.5°C to 25 °C showed a partial 
change back to more a-helical spectra with the D144N and D144N/D147N spectra, in 
particular, showing negative lobes at 208 and 222 nm (Figure 2 Id), which are similar to, 
but not identical, to the spectra at 25°C prior to thermal denaturation (Figure 21a). These 
data suggest that the mutant proteins unfold to a different denatured state structure at 
72.5°C than the wild type protein.
3. GdtiHCl Denaturation o f  Wild Type and M utant HaPrP—  To further investigate the 
unfolding o f  the PrP helix 1 mutants, GdnHCl unfolded samples o f wild type D144N, 
D147N and D144N/D147N PrP at pH 6.0 were monitored using CD spectroscopy at 222 
nm. As shown in Figure 23, the sigmoid shapes o f  the unfolding curves indicated that all 
the constructs underwent a cooperative two-state transition. All unfolding reactions were 
found to be reversible (data not shown). Thermodynamic parameters, determined from 
the unfolding data assuming a two-state transition, are shown in Table 5. The wild type 
protein had a free energy o f  conformation [AGfHsO)] similar to that for recombinant full 
length ovine PrP (Rezaei et al. 2000), but lower than that reported for full-length murine 
PrP (Homemann and Glockshuber 1998). The mutant proteins have lower AG(H20) 
values and transition midpoints ([GdnHCl]i/2) than wild type PrP. The cooperativities for 
the unfolding (m) indicated that the wild type (m = 7.86 kJ/mol/M), D144N (m = 7.43 
kJ/mol/M) and D147N (m = 7.85 kJ/mol/M) PrP unfolded more cooperatively than did 
the D144N/D147N (m = 6.04 kJ/mol/M) mutant. The AG(H20) and [GdnHCl]y2 data
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Slope AG(H20 )  [GdnHCl]i/2 m
J  m<
M'1)Construct (°C) f C ’1) (kJ mol’1) (M) (kJ mo1 *
Wild type 61.3 ± 0 .7  0.174 ± 0 .016  16.0 ± 5 .4  2.02 ± 0.08 7.9 ± 2 .3
D144N 63.5 ± 0 .3  0.112 ± 0 .008  13.7 ± 1 .6  1.84 ± 0 .0 2  7.4 ± 1 .0
D147N 62.9 ± 0 .4  0.139 ± 0 .008  15.1 ± 1.6 1.93 ± 0 .0 8  7.9 ± 0 .5
D144N/D147N 61.0 ± 0 .5  0.0986 ± 0 .005  10.9 ± 1 .9  1.80 ± 0 .0 9  6.0 ± 0 .8
Table 5. Thermodynamic parameters for thermal and GdnHCl denaturation o f wild 
type and helix 1 mutant hamster PrP protein. Transition midpoints (Tm) and Slope 
values (means ±  standard deviation) were determined from three individual thermal 
denaturation experiments for each protein. AG(H20 ), m and [GdnHCl]m  values 
(means ±  range) were determined from 2 individual denaturation experiments using
GdnHCl for each protein.
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support the conclusion from the thermal denaturation experiments that the mutants unfold 
somewhat differently than the wild type protein. However, while the mutants tended to be 
slightly more stable against thermal denaturation, they were slightly less stable than the 
wild type protein to GdnHCl-induced denaturation. Nonetheless, neither the thermal nor 
the chemical denaturation data suggest that the overall stability o f  PrP is substantially 
dependent upon the proposed helix 1 Asp residues and their salt bridges.
4. Cell-free Conversion Reactions—It remained to be determined whether the helix 1 
aspartic acid residues are involved in the interactions necessary for the conversion o f  PrP- 
sen to PrP-res. Specifically, i f  the critical interaction required for the conversion involved 
intermolecular ionic bonds between aspartic acid (D144 and D147) and arginine (R148 
and R151) residues as proposed (Morrissey and Shakhnovich 1999), one would expect 
conversion o f  the mutants lacking the Asp residues to be inhibited. In order to address 
this question the D144N, D147N and D144N/D147N PrP mutants were expressed in 
mammalian cells. Transfection and amplification o f  protein expression using the pSFF 
retroviral vector with \|/2 and PA317 cells and expression o f  HaPrP by this method has 
been described elsewhere (Kocisko et al. 1994; Robertson et al. 1992). The basic process 
is the \|/2 and PA317 cells are transfected with the retroviral vector pSFF containing the 
desired HaPrP insert in order infect the cells, getting them to incorporate both the 
retroviral and HaPrP genes into their chromosomes. Once infected the cells express both 
viral and HaPrP proteins. The viral proteins facilitate retroviral replication within the host 
cells forming virions containing the retroviral genes, including the inserted HaPrP gene,
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which are secreted into the medium and subsequently infect other cells. Viral and HaPrP 
protein expression, therefore, amplify and persist after transfection. HaPrP expression 
following transfection was confirmed using immunostaining with the HaPrP specific 
antibody 3F4. Figure 24 shows the immunostained cells transfected with the retroviral 
vector pSFF containing gene inserts for wild type, D144N, D147N, or D144N/D147N  
HaPrP. The red staining for the HaPrP pSFF transfected cells compared to no staining for 
controls transfected with pSFF lacking a HaPrP gene, confirms the expression o f  the 
HaPrP protein constructs. Immunostaining was also performed using an antibody (18-8) 
directed towards the Gag retroviral capsid protein to confirm expression of viral 
structural protein. All constructs stained positive for Gag expression indicating the cells 
were expressing retroviral capsid structural proteins (Figure 25).
After confirming HaPrP expression, cells were radiolabeled using [35S]- 
methionine and analyzed using the cell-free conversion assay (Kocisko et al. 1994). The 
assay is performed by “seeding” the conversion o f  [35S]-labeled PrP-sen using PrP-res 
from the brains o f  hamsters infected with 263K scrapie. After an incubation period, 
newly converted (radiolabeled), partially protease-resistant PrP is detected following 
digestion with PK by SDS-PAGE and phosphor autoradiography (Caughey et al. 2001; 
Kocisko et al. 1994). Conversion reactions were limited to PrP-sen that was 
metabolically radiolabeled in mammalian cells because o f  difficulties in generating [35S]- 
methionine labeled PrP-sen with sufficient specific activity when expressed in E. coli. 
Figure 26 shows the results o f  conversion reactions performed in the presence o f  
detergents and GdnHCl using purified 263K hamster PrP-res to drive the reaction. Figure
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e
Figure 24. Immunostaining using the anti-PrP antibody 3F4 of-\|/2 and PA317 mouse 
fibroblast cells transfected with the retroviral vector pSFF-containing gene inserts for 
wild type and mutant hamster PrP lacking the GPI anchor. The red staining in panels 
a-d, which resulted from the reaction product o f  antibody bound peroxidase with AEC 
substrate, indicate that cells transfected with wild type (a), D144N (b), D147N (c), and 
D144N/D147N (d) HaPrP containing pSFF retroviral vectors express PrP. The 
negative control (e), containing non-transfected \|/2 and PA317 cells, shows no red 
staining, suggesting the staining is dependent on the expression o f  PrP.
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a b
d
Figure 25. Immunostaining using the antibody 18-8 of-\|f2 and PA317 mouse 
fibroblast cells transfected with the retroviral vector pSFF-containing gene inserts for 
wild type and mutant hamster PrP lacking the GPI anchor. The 18-8 antibody is 
directed against the retrovirus capsid structural protein Gag. The red staining, which 
resulted from the reaction product o f  antibody bound peroxidase with AEG substrate, 
in panels a-d indicates that cells transfected with the wild type (a), D144N (b), D147N  
(c), and D144N/D147N (d) HaPrP containing pSFF retroviral vectors express Gag. 
The negative control (e), containing \|/2 and PA317 cells alone, shows no red staining, 
suggesting the staining is dependent on transfection with the pSFF retroviral vector
and the expression o f  Gag protein.
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26a shows the undigested radiolabeled PrP post incubation without (lanes 1 to 4) and 
with (lanes 5 to 8) PrP-res. Lanes 9 to 16 show the remaining portion o f  the same samples 
after a 1-hour digestion with PK. The lanes incubated without PrP-res had no protease 
resistant bands. However, samples incubated in the presence o f  PrP-res showed distinct 
protease resistant [35S]PrP bands that, like PK-digestion products o f  brain-derived PrP-res 
itself, were 6 to 7 kDa lower in molecular mass than full-length precursor [35S]PrP-sen 
molecules. Quantification o f  the proportion o f  the input [35S]PrP-sen converted to PK- 
resistant bands o f  19-26 kDa (i.e. conversion efficiency) is shown in Figure 26b. In this 
case all three mutants converted (lanes 14 to 16) with statistically indistinguishable 
efficiencies from the wild type PrP control (lane 13). These data are not consistent with 
the idea proposed by Morrissey and Shakhnovich (Morrissey and Shakhnovich 1999) that 
PrP-res is stabilized by intermolecular salt bridges. The data are also inconsistent with the 
possibility that the previously observed inhibition o f  conversion o f  PrP helix 1 deletion 
mutants (Vorberg et al. 2001) was due to the loss o f  the putative salt bridge-forming 
carboxylate groups on the aspartate side chains. Thus, these date suggest that aspartic 
acid residues 144 and 147 are not essential for the conversion o f  PrP-sen to PrP-res in the 
presence o f  detergents and GdnHCl.
Because the above conversion conditions (especially the presence o f  GdnHCl) 
may have blocked the ionic interactions necessary for the presence o f  the helix 1 salt 
bridges, conversion reactions were performed without the GdnHCl pretreatment using 
guanidine-free conversion reaction conditions developed by Horiuchi to better 
approximate the physiological conditions at which PrP-res formation occurs by removing
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Figure 26. Conversion o f  wild type and mutant PrP-sen molecules using GdnHCl 
pretreated PrP-res and detergents in the conversion buffer, (a) GdnHCl pretreated, 
cell-free conversion o f  wild type (lanes 1, 5, 9, and 13), D144N (lanes 2, 6, 10, and 
14), D147N (lanes 3, 7, 11, and 15) and D144N/D147N (lanes 4, 8, 12, and 16) 35S- 
PrP-sen into protease resistant forms before and after treatment with PK.Lanes 1-8 
contain 10% o f  the total reaction mixture prior to PK digestion. The remaining 90% o f  
the samples after PK-digestion are shown in lanes 9-16. Molecular mass markers 
(kDa) are indicated at the left, (b) The means and standard deviations (n = 3) o f  the 
conversion efficiencies o f  the wild type and mutant PrP-sen into PrP-res were 
determined by comparing and appropriately factoring the integrated intensities o f  
bands from the 20-30-kDa (lanes 13-16) and the 26-37-kDa (lanes 5-8) bands.
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Figure 27. Conversion o f  wild type and mutant PrP-sen molecules without GdnHCl 
pretreatment o f  PrP-res. (a) GdnHCl-ffee cell-free conversion o f  wild type (lanes 1, 5, 
9, and 13), D144N (lanes 2, 6 ,1 0 , and 14), D147N (lanes 3, 7 ,1 1 , and 15) and
D144N/D147N (lanes 4, 8, 12, and 16) S-PrP-sen into protease resistant forms 
before and after treatment with PK. Molecular mass markers (kDa) are indicated at the 
left, (b) The means and standard deviations (n = 3) o f  the conversion efficiencies o f  
the wild type and mutant PrP-sen into PrP-res were determined as described in the 
Experimental Methods and the Figure 25 caption.
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the denaturant and lowering the amount o f  detergent in the reaction buffer (Horiuchi and 
Caughey 1999; see Table 6 for a summary o f  all conversion reaction conditions used in 
this report). Results o f  the guanidine-free conversions are shown in Figures 27a and 27b. 
The conversion efficiencies for all constructs were statistically indistinguishable, 
suggesting the aspartates have no effect on conversion under guanidine-free conditions.
While the guanidine-free conversion reactions lacked the salt-bridge destabilizing 
cationic denaturant guanidine, reactions still contained a substantial amount o f  anionic 
detergent which might have disrupted any stabilizing salt bridges. To test the conversion 
under conditions which contained a minimal amount o f  detergents and no ionic 
denaturants, reactions were performed under denaturant-free/low detergent conditions 
using conversion buffer containing only a minimal amount o f  the anionic detergent 
zwittergent 3-14 and using buffer containing the nonionic denaturant urea and zwittergent 
3-14. Zwittergent 3-14 is used as a stabilizer in the storage buffer for purified PrP-res. Its 
presence in conversion reactions proved to be essential because denaturant and detergent- 
free conversion reactions performed using purified PrP-res in which the detergent 
containing storage buffer was replaced with water were unsuccessful (data not shown). 
The poor results were most likely due to the difficulty in obtaining repeatable pipetting o f  
the PrP-res. Thus, a small amount o f  zwittergent 3-14 was present for all conversion 
reactions performed using purified PrP-res. Results o f  the denaturant-free/low detergent 
conversion reaction are shown in Figures 28a and 28b. Figure 28a clearly shows that 
conversion product was obtained for all constructs. The conversion efficiencies for all 
constructs were, however, statistically indistinguishable (Figure 28b).
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Figure 28. Conversion o f  wild type and mutant PrP-sen molecules using denaturant- 
free/low detergent conditions, (a) Denaturant-free/low detergent cell-free conversion 
o f  wild type (lanes 1, 5, 9, and 13), D144N (lanes 2, 6, 10, and 14), D147N (lanes 3, 7, 
11, and 15) and D144N/D147N (lanes 4, 8, 12, and 16) 35S-PrP-sen into protease 
resistant forms before and after treatment with PK. Molecular mass markers (kDa) are 
indicated at the left, (b) The means and standard deviations (n = 3) o f  the conversion 
efficiencies o f  the wild type and mutant PrP-sen into PrP-res were determined as 
described in the Experimental Methods and the Figure 25 caption.
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Figure 29. Conversion o f  wild type and mutant PrP-sen molecules using urea 
pretreatment o f  PrP-res and low detergent conditions, (a) Urea and low detergent cell- 
free conversion o f  wild type (lanes 1, 5, 9, and 13), D144N (lanes 2, 6, 10, and 14), 
D147N (lanes 3, 7, 11, and 15) and D144N/D147N (lanes 4, 8 ,12 , and 16) 35S-PrP- 
sen into protease resistant forms before and after treatment with PK. Molecular mass 
markers (kDa) are indicated at the left, (b) The means and standard deviations (n = 3) 
o f  the conversion efficiencies o f  the wild type and mutant PrP-sen into PrP-res were 
determined as described in the Experimental Methods and the Figure 25 caption.
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Conversion reactions performed using urea pretreated purified PrP-res (Figure 29) 
resulted in no dramatic differences between the conversion efficiencies for the mutant 
and wild type proteins.
In order to obtain reaction conditions completely lacking salt-bridge interfering 
ionic detergents and denaturant, conversion reactions were performed using microsomal 
PrP-res in place o f  purified PrP-res following a recently described method (Caughey et 
al. 2001). This method uses a crude scrapie brain microsome fraction containing PrP-res 
to drive conversion. These conversion reactions more closely mimic conditions found on 
cell membranes where PrP-sen is located and most likely converted in scrapie-infected 
cells (Caughey and Raymond 1991; Caughey et al. 1991a). Under these conditions the 
PrP mutants converted with 2-3 times the conversion efficiency as the wild type PrP 
(Figure 30a and b). Thus, the replacement o f  the aspartic acid residues with asparagines 
at positions 144 and 147 enhanced, rather than prevented, conversion to PrP-res.
The influence o f the helix 1 salt bridges on PrP conversion was also tested using 
[3SS]-labeled PrP-sen mutants where the aspartic acids at positions 144 and 147 were 
individually or both replaced with alanines. These replacements should have prevented 
ion-dipole interactions in addition to ion-ion interactions between the side-chains o f  the 
residues involved in the helix 1 salt bridges in wild type PrP. If the increases in 
conversion efficiencies o f  the D-to-N HaPrP mutants were solely due to the loss o f  a salt 
bridge or any other interaction that stabilizes the native a-helical structure from 
converting to PrP-res then one would expect that the D-to-A mutant proteins would show 
the same conversion behavior as the respective D-to-N mutants. After subcloning the
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desired D to A  HaPrP mutants into the pSFF retroviral vector, transfecting v|/2 and PA317 
cells, and confirming PrP and Gag protein expression as described above (data not 
shown), cells were radiolabeled with [35S]-methionine. Using radiolabeled D144A, 
D147A and D144A/D147A PrP-sen mutants in the detergent and GdnHCl-free 
conversion reactions produced the expected conversion products (Figure 31a, compare 
lanes 9-16 to lanes 1-8). The conversion efficiencies o f  the D-to-A mutant PrP constructs 
were roughly 3-4 times as efficient as the conversion efficiency o f  the wild type PrP 
(Figure 31b), confirming that mutations expected to disrupt the helix 1 salt bridges 
promote PrP-res-induced conversion. The fact that D-to-A mutants were even more 
efficiently converted than the D-to-N mutants suggests that in the latter, some stabilizing 
interactions between the N144, N147 and the arginines in helix 1 (presumably ion-dipole 
interactions) still occur.
5. PrP-sen Binding to PrP-res—To determine i f  there are any PrP-res binding 
differences between the wild type and mutant PrP-sen, binding experiments were 
performed using microsomal and purified PrP-res. As mentioned above there are two 
kinetically separable steps in the interactions o f  PrP-sen and PrP-res leading to 
conversion o f  PrP-sen to the PK-resistant state: the binding o f  PrP-sen to PrP-res 
followed by the conversion o f  PrP-sen to the PK resistant state (DebBurman et al. 1997; 
Horiuchi and Caughey 1999; Horiuchi et al. 2000). Two different binding experiments 
were performed to test for differences between PrP-sen and PrP-res in the presence and
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Figure 30. D144N and D147N PrP mutants convert more efficiently than wild type 
PrP-sen without denaturants or detergents, (a) Conversions o f  wild type (lanes 1, 5, 9, 
and 13), D144N (lanes 2, 6, 10, and 14), D147N (lanes 3, 7, 11, and 15) and 
D144N/D147N (lanes 4, 8, 12, and 16) 35S-PrP-sen into PrP-res performed without the 
presence o f  denaturants or detergents before and after treatment with PK. Reactions 
were performed using microsomal PrP-res derived from crude brain homogenates o f  
uninfected and 263K scrapie-infected hamsters as described in the Experimental 
Methods, (b) The means and standard deviations (n = 5) o f  the conversion efficiencies 
for wild type and mutant PrP’s are indicated. Conversion efficiencies were determined 
as described in the Experimental M ethods and Figure 25 caption. The difference 
between the mean o f  the wild type and each mutant PrP was assessed with a one-way 
ANOVA by Dunnett’s multiple comparison test. Statistical significance o f  the 
differences is designated by * and ** for P<0.05 and P<0.01 respectively.
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Figure 31. D144A and D147A PrP mutants convert with increased efficiency 
relative to wild type PrP without denaturants or detergents, (a) Conversions o f wild 
type (lanes 1, 5, 9, and 13), D144A (lanes 2, 6, 10, and 14), D147A (lanes 3, 7, 11, 
and 15) and D144A/D147A (lanes 4, 8, 12, and 16) 35S-PrP-sen into PrP-res 
performed without the presence o f  denaturants or detergents before and after 
treatment with PK. Reactions were performed using microsomal PrP-res derived 
from crude brain homogenates o f  uninfected and 263K scrapie-infected hamsters as 
described in the Experimental Methods, (b) The means and standard deviations (n =  
5) o f  the conversion efficiencies for wild type and mutant PrP’s are indicated. 
Conversion efficiencies were determined as described in the Experimental Methods 
and Figure 25 caption. The difference between the mean o f  the wild type and each 
mutant PrP was assessed the same as described in the Figure 29 caption.
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absence o f  denaturant. Experiments using purified PrP-res were performed in the 
presence o f  the detergents sarkosyl and zwittergent 3-14 at physiological salt 
concentrations using a previously described method (Horiuchi and Caughey 1999). PrP- 
res was incubated with [35S]PrP-sen and then pelleted, along with any bound [35S]PrP-sen 
by centrifugation. Greater than 95% o f  the PrP-res pellets using this method and therefore 
any [35S]PrP-sen detected in the pellet fraction is indicative o f  PrP-res bound PrP-sen 
(Horiuchi and Caughey 1999). For all o f  the PrP-sen constructs the binding was PrP-res 
dependent and the average amount o f  [35S]PrP-sen present in the respective pellets ranged 
from 52 to 66% o f  the total detectable [35S]PrP-sen, while the amount present in samples 
lacking PrP-res ranged from 3 to 11% (Figure 32). The difference between the PrP-res 
containing and lacking samples is indicative o f  the PrP-res-dependent binding. The 
difference values are statistically indistinguishable suggesting that there are no 
differences in binding. This result is not surprising since the conversion efficiencies 
resulting from conversion reactions performed under comparable conditions were 
essentially indistinguishable.
Binding experiments using microsomal PrP-res were performed to determine if  
the conversion differences seen between the wild type and mutant PrP-sen constructs 
were due solely to PrP-res binding differences. If this were the case, one would expect to 
detect twice as much o f  the asparagine mutant PrP-sen molecules bound to PrP-res as 
wild type PrP-sen. Results from the microsomal PrP-res binding experiments are shown 
in Figure 33. In the presence o f  PrP-res-containing microsomes, between 68 and 69% o f  
the [35S]PrP-sen was present in the pellet. Unlike the purified PrP-res binding
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experiments however, there was a significant amount o f  PrP-res independent binding 
since pellets o f  the normal brain microsomes lacking PrP-res contained from 49 to 55% 
o f  the [35S]PrP-sen. This resulted in the PrP-res binding dependent differences being 
significantly lower than the differences obtained in the purified PrP-res binding 
experiments. As a result evaluating the statistical differences between samples was 
problematic because after propagating the error, the relative standard deviation values 
were high, ranging from 32% for the D144N/D147N data to 66% for the wild type PrP. 
Thus, while the data suggest that binding differences are not the cause o f  the observed 
conversion efficiency differences between the wild type and helix 1 mutant proteins since 
the means o f the PrP-res dependent binding for all samples were similar, the development 
o f an improved binding assay is needed to generate data with lower relative standard 
deviations in order to statistically confirm the results.
6. Discussion—This investigation sought to determine the role o f  the putative Asp-Arg 
helix 1 salt bridges in the stability o f  PrP-sen and whether the same residues proposed to 
be involved in the salt bridges play a role in the conversion o f  PrP-sen to PrP-res. It 
appears from the data that helix 1 does not behave as has been previously proposed 
(Morrissey and Shakhnovich 1999). That is, the data suggest that the helix 1 salt bridges 
do not substantially stabilize PrP under native conditions and, intermolecular salt bridge 
formation between the same salt bridge residues is not critical for the conversion o f  PrP- 
sen to PrP-res. Instead it appears that the aspartic acid residues affect how the protein 
unfolds and provide stability against the conversion o f PrP-sen to PrP-res.
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The contribution o f  surface salt bridges such as those proposed to exist on helix 1 
has generally been considered to contribute little to the overall stability o f  protein 
structures. It has been reported that salt bridges buried in the protein interior contribute as 
much as 20.9 kJ/mol while surface salt bridges contribute only 2.1 to 5.0 kJ/mol to 
protein free energies o f  conformation (Matthews 1993; Nakamura 1996). Our data are 
consistent with this consensus as the Gibbs free energies o f  conformation o f  the D144N, 
D147N, and D144N/D147N mutants were estimated by GdnHCl unfolding to be only 
2.3, 0.9 and 5.1 kJ/mol lower respectively than wild type hamster PrP-sen. These data 
combined with the fact the CD spectra o f  the mutants are identical to the wild type 
protein at 25 °C suggest that there is no unusual stability gain due to ionic interactions 
involving the aspartic acid and arginine residues o f  helix 1 o f  hamster PrP-sen.
Although the effects o f  the helix 1 mutations on the overall free energy o f PrP are 
modest, the localized effects on helix 1 stability might be more dramatic. At pHs below  
4.0 three-state unfolding transitions have been reported for recombinant human PrP in the 
presence o f  GdnHCl and urea with salt ( Jackson et al. 1999; Swietnicki et a l  1997). It is 
tempting to think that the first transition might involve the unfolding o f  a localized 
domain containing helix 1 because this helix has been modeled to lose helical structure at 
low pH (Alonso and Daggett 2001) and has been shown to more easily undergo 
hydrogen-deuterium exchange than the central portions o f  helices 2 and 3 (Liu et al. 
1999). This suggests a looser, less compact structure that might unfold more readily.
Such a transition at low pH might be dependent on the protonation and ionic screening o f  
the aspartic acids disrupting the salt bridges leading to the unfolding o f  helix 1 prior to
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the unfolding o f the remaining helices. I f  such a three-state transition were occurring 
under the conditions o f our experiments (i.e., pH 6), one might expect to have detected it 
in our unfolding curves monitored at 222 nm since helix 1 makes up 18% o f the total 
helix content o f  PrP-sen. However, our unfolding curves o f  both the wild type and helix 1 
mutants suggested only two-state processes without any additional inflection points. 
Nonetheless the helix 1 mutations reduced the slopes o f  the transition regions for the 
thermal denaturation curves indicating the mutants unfold less cooperatively than the 
wild type protein. This effect was especially apparent for the D144N/D147N double 
mutant. Presumably, replacement o f  the helix 1 aspartates destabilizes helix 1 to some 
extent but our data provide no evidence that this allows helix 1 to unfold independently 
o f  the other helices under the conditions suitable for the PrP-res-induced conversion 
reaction. One possibility is that helix 1 is already partially unfolded under these 
conditions reducing our chances o f  detecting any independent unfolding in the 
denaturation curves. In any case, the low structural resolution o f  CD spectroscopy 
prevents us from fully discerning the conformational effects o f  the aspartate replacement 
and elimination o f  putative helix 1 salt bridges.
The differences between unfolding cooperativities o f  the mutant and wild type 
PrP molecules raise the possibility that the helix 1 aspartic acids are involved with 
stabilizing interactions other than the intramolecular salt bridges. Eleven different salt 
bridges involving seven different anionic residues and eight different cationic residues 
were predicted in molecular dynamic simulations o f  human and Syrian hamster PrP-sen 
as reported by Zuegg and Gready (Zuegg and Gready 1999). Five o f  the eleven proposed
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salt bridges involve either D144 or D147 including, in addition to the intrahelix salt 
bridges investigated here, D144-H140, D144-R208 and D147-H140. The differences in 
unfolding cooperativities could result from the elimination o f  any o f  the five proposed 
salt bridges.
Protein unfolding cooperativity differences can also result from differences in the 
stabilities o f  the denatured state conformations (Matthews 1993; Shortle 1996). The PrP 
thermal denaturation data show that the denatured states o f  the mutants at 72.5°C differ 
from the wild type protein suggesting the mutants unfold via somewhat different 
conformations. Such alterations in the unfolding pathway, rather than differences in 
overall thermodynamic stability, could account for the increased conversion efficiencies 
seen in our cell-free conversion experiments. Consistent with this possibility are 
observations that decreased thermodynamic stability o f  PrP-sen is not a common 
characteristic o f  mutants associated with familial Creutzfeldt-Jakob disease, Gerstmann- 
Straussler-Scheinker syndrome and fatal familial insomnia (Liemann and Glockshuber 
1999). Reasons proposed for how mutations associated with inherited forms o f  
spongiform encephalopathies lead to disease include: a) an increase in the stability o f  
PrP-res; b) an increased number o f  alternative conformations in equilibrium with PrP-sen 
which may act as precursors to PrP-res; and c) differences in PrP-sen folding kinetics 
with accumulation o f  PrP-res-like kinetic folding intermediates (Liemann and 
Glockshuber 1999). Any o f  these reasons could apply as reasons for the increase in PrP- 
res formation seen in the cell-free conversion reactions using microsomal PrP-res and the 
PrP-sen helix 1 mutants studied herein. Binding differences between the wild type and
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mutant PrP-sen molecules with PrP-res could be another reason for the observed 
conversion differences. However, the binding data, though inconclusive, suggests there 
are no binding differences.
Thus, the helix 1 mutants may populate intermediate, partially unfolded 
conformations along the PrP-sen to PrP-res conversion pathway to a greater extent than 
wild type PrP. Conversely, because the helix 1 mutants do not unfold to the same P-sheet 
containing denatured structures at 62.5 and 72.5°C as the wild type protein, it is possible 
that the mutants populate an off-pathway P-sheet conformation to a lesser extent than the 
wild type protein. The formation o f  an off-pathway p-oligomer has been previously 
reported to occur during amyloid fibril formation o f  recombinant PrP 27-30 (Baskakov et 
al. 2002). The more disordered conformations seen with the helix 1 mutants might be 
more convertible to PrP-res than the more p-sheet conformation o f  wild type PrP during 
thermal denaturation. However, Rezaei et al. (Rezaei et al. 2002) recently reported that 
the thermally denatured conformations o f  sheep PrP variants associated with low  
susceptibility to scrapie infection contained more disordered structure while the highly 
susceptible variants contained more p-sheet. The sheep PrP variant data is not consistent 
with our data because our mutants show more disordered structure but convert with 
higher efficiencies relative to the wild type protein. Thus, it appears that unfolding to a 
more disordered conformation is not necessarily associated with increased susceptibility 
to PrP-res formation. Rather, our data suggest that our D-to-N mutants populate 
intermediate conformations that contain unspecified secondary structures with less P- 
sheet that are more susceptible to PrP-res formation than wild type PrP.
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Considering all the data, three mechanistic pathways leading to PrP-res formation 
can be proposed (Figure 34) assuming the conversion is based on the autocatalytic seeded 
polymerization model (Come eta l. 1993; Griffith 1967; Jarrett and Lansbury, Jr. 1993; 
Lansbury, Jr. and Caughey 1995). Also, assuming PrP-sen is in equilibrium with 
convertible, intermediate and non-convertible conformations, the pathways vary 
depending on which conformation binds to PrP-res. In pathway (a), the intermediate PrP- 
sen conformation binds to PrP-res. After binding, the PrP-sen molecule can undergo a 
conformational transition to either the convertible conformation or to the off-pathway 
non-convertible conformation. PrP-res is only formed when the bound PrP-sen molecule 
attains the convertible conformation. In pathway (b), convertible PrP-sen binds to PrP-res 
and then can convert directly to PrP-res. In pathway (c), a non-convertible PrP-sen 
conformer binds to PrP-res and must transform to intermediate and/or convertible PrP- 
sen prior to converting to PrP-res. Evidence for the existence o f  bound, but non- 
convertible states has come from previous studies o f  interspecies conversion reactions 
(Horiuchi et al. 2000). In the case o f  the helix 1 mutants, PrP-sen is proposed to be less 
likely to adopt the non-convertible conformation resulting in more conversion o f  the 
mutant PrP-sen molecules to PrP-res than the wild type PrP-sen.
D . C o n c l u s io n s
In summary, these results suggest that PrP-sen is not substantially stabilized by 
the aspartic acid-arginine salt bridges. However, the helix 1 mutants unfold less
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cooperatively and do not attain the same p-sheet denatured state as the wild type protein 
upon thermal denaturation. Cell-free conversion data suggest the salt bridge residues are 
not critical for the formation o f PrP-res as protease resistant material was generated in all 
conversion reactions performed with and without the presence o f  detergents and 
denaturants. The conversion efficiencies o f  the mutants in the absence o f  detergents and 
denaturants, conditions favorable to salt bridge formation, are higher than the wild type 
protein, indicating that the elimination o f  the anionic charge o f  the aspartic acids 
increased either the convertibility or the binding o f  PrP-sen to PrP-res. Results o f  binding 
experiments suggest that the conversion differences are not due to binding differences, 
but rather in the convertibility o f  the PrP-sen. An increase in convertibility could possibly 
be explained by the elimination o f  an off-pathway conformation along the conformational 
pathway leading to conversion to PrP-res.
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